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White spot syndrome virus (WSSV) is a virulent pathogen known to infect 
penaeid shrimp and other crustaceans. It has bacilliform morphology with a tail-like 
appendage at one end. The envelope consists of four major proteins. Here we report the 
localization and crystal structure of two major envelope proteins VP26 and VP28 from 
WSSV at 2.2 and 2.0Å respectively. Their structures are being reported for the first time 
for WSSV. Both proteins adopt β-barrels architecture with a protruding region. 
Furthermore, we reinvestigated the localization of VP26 and VP28 using immunoelectron 
microscopy. Our localization study suggests that VP26 and VP28 are on the outer surface 
of the virus and resembled as a spike-like structure on the WSSV envelope, this is the 
first convincing observation for VP26. The spike-like structure of VP26 and VP28 
observed in our immuno-electron microscopy images matches well with the trimeric 
shape of the crystal structure. Based on our present studies combined with previous 
findings from other groups, we propose that VP26 and VP28 may anchor on the viral 
envelope membrane via their predicted N-terminal transmembrane regions, while leaving 
the core β-barrel to protrude outside the envelope to interact with the host receptor or to 
fuse with the host cell membrane for effective viral infection.  
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Viruses can only be reproduced by invading and taking over host cells due to their 
lack of cellular machinery for reproduction. The term “virus”, which comes from the 
Latin word virus, means poison things and usually refers to those particles that infect 
eukaryotes including both multi-cellular and many single-cell organisms and prokaryotes 
(phages) and archae as well. Typically, these particles carry a small amount of nuclei 
acids (either DNA or RNA) surrounded by some forms of protective coat consisting of 
proteins, or proteins and lipids (Knipe and Howley 2001). 
 
  The discovery that viruses are very abundant in natural waters, surpassing 
bacteria by an order of magnitude, has inspired a resurgence of interest in viruses in the 
aquatic environment (Wommack and Colwell 2000). The viral pathogen is a major threat, 
especially for the aquaculture industry. Intensive cultivation, inadequate sanitation and 
worldwide trade of livestock have greatly increased the chance of virus outbreak that 
consequently causing catastrophic economic losses. Therefore, effective control and 
prevention of viral disease is of upmost important to ensure the long-term operation of 
aquaculture. 
 
In the shrimp aquaculture industry, out of more than 20 strains of viruses have 
been reported, among which White Spot Syndrome Virus (WSSV) is the most serious 
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pathogen (Chou et al. 1995; Lo et al. 1996; Chen et al. 1997). WSSV first appeared in the 
1990s in Taiwan and has since been spread quickly to Southeast Asia, the Indian 
continent and the Central- and Latin America (Xie and Yang 2005). The virulence of 
WSSV is very high, resulting in a mortality rate of up to 90 to 100% within 3 to 7 days, 
which can devastate the regional shrimp culture industry. A major outbreak of WSSV 
infection in 1993 resulted in a 70% reduction in production of shrimps in China (Chen et 
al. 1997; Cen 1998). The worldwide economic loss caused by WSSV outbreak is 
catastrophic and in the range of multi-billion U.S. dollars.  
 
The symptom of the disease caused by this virus include a red color on the entire 
body and obvious white spots on the carapace, appendages and the inside surface of body. 
That is why scientists named this virus as “white spot syndrome virus”. Most organs and 
tissues of the shrimp, except for hepatopancreatocytes and epithelial cells of the midgut, 
can be infected by WSSV. Moreover, WSSV has a broad range of hosts, including salt 
and brackish water penaeid, crab, spiny lobster, freshwater shrimps and crayfishs (Figure 
1.1) (Chou et al. 1995; Wang et al. 1995; Lo et al. 1996; Chen et al. 1997; Huang and 
Song 1999; Chen et al. 2000; Huang et al. 2001). As such, WSSV is becoming an 
epizootic disease that causes great threat not only to the shrimp aquaculture industry but 















Figure 1.1 Clinical sign of WSSV in shrimp and crayfish 
 
(A) WSSV infected shrimp (P. monodon) with an apparent presence of white spots on the 
cuticle. 
(B) Crayfish (Cherax quadricarinatus) one of WSSV infected hosts, was used in our 





Prevention and inhibition of infection by this virus, however, is very difficult 
largely due to the ability of WSSV to survive for a long period of time in the environment 
(around 2 years in a shrimp pond) and also due to a poor understanding of this virus at the 
molecular level (Yang et al. 2001). At present, except for the use of nonspecific 
immunostimulants such as bacterial glycans (with minimal protection) and low-density 
culture conditions, there is no effective treatment protocol for this disease. Therefore 
novel control strategies against this virus are highly desirable (Westenberg et al. 2005). 
 
In the following sections, some basic information of the biology on WSSV including its 
morphology, genome structure and the taxonomy will be introduced in detail. These 
would provide a in-depth and comprehensive understanding of the uniqueness of this 
virus and the significance of scientific research on the related disease.  
 
 
1.1.2 Morphology of WSSV 
 
As mentioned before, WSSV is the major viral pathogen of shrimp with a very 
high virulence. In the past decade, WSSV has attracted intensive investigation resulting 
in many exciting research progress. The morphology of WSSV has been studied by 
electron microscopy technology (Chou et al. 1995; Wang et al. 1995; Wongteerasupaya 
et al. 1995; Durand et al. 1997; Lu et al. 1997; Leu et al. 2005). A previous electron 
microscopy study showed the that intact WSSV virion is a non-occluded, enveloped 
particle with an olive-to-bacilliform shape. The average size of the intact viral particle is 
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approximately 110-130 nm in diameter and 260-350 nm in length. The most prominent 
feature of WSSV is the presence of a long tail-like envelope extension at one extremity 
that highly resemble to a bacterial flagellum (Huang et al. 2001). The negatively stained 
intact WSSV virions observed under EM are shown in Figure 1.2. 
 
The WSSV virion is very sensitive to detergents and the envelope proteins wll be 
removed from the virion when treated with 1% Triton X-100 to expose the nucleocapsid 
(Figure 1.3). As shown in Figure 1.4, the naked viral nucleocapsid is about 80×350 nm 
(Huang et al. 2001). Interestingly, the nucleocapsid is composed of 15 or 16 vertical 
segments that are perpendicular to the long axis and about 18 to 20 nm thick. Huang and 
coworkers (Huang et al. 2001) have proposed that each segment is composed of double 
rows of 14 globular subunits of 8 nm in diameter (Figure 1.5). A “ring” structure could 
also be seen in some of the degraded viral nucleocapsid. However, the existence of these 
discrete globular subunits is debatable. In a recent paper, Leu et al (2005) have identified 
that VP664, the largest viral structural protein ever found, is the major component of the 
nucleocapsid. Gold labeling Immunoelectron microscopy showed that the gold particles 
indicating the location of VP664 were regularly distributed around the periphery of the 
nucleocapsid with a periodicity that matched the characteristic stacked ring subunits 
which appear as striations. From this observation, they hypothesized that the stacked, 



















Figure 1.2 EM of negatively stained intact WSSV virions  
 
A) Purified WSSV is shown with the Scale bar equals to 416 nm.  
B) An electron micrograph of a single WSSV virion. Note the long, tail-like structure that 






















Figure 1.3 Electron micrograph of WSSV particles treated with 1% Triton X-100  
 
This treatment leads to the distinct separation of the double layered structure of the viral 
envelop as shown in A (arrow →). The nucleocapsid wrapped inside the double layer 
envelope shows a "spindle" shape at one extremity (arrow →), while a ‘papilla’ shape 
structure in the other extremity (arrow →) as shown in B. In A, scale bar equals to 250 














Figure 1.4 EM of negatively stained, naked WSSV nucleocapsids  
 
The average size of the nucleocapsid in A is 80 nm in diameter and 350 nm in length with 
the scale bar equals to 50 nm. Note the 15 conspicuous, vertical helix located horizontally 
along the long axis of the naked rod-shape nucleocapsid core in B. Each helix has two 
parallel striations which contain 14 global capsomers or subunit. Scale bar in B equals to 









Figure 1.5  Proposed WSSV structure  
 
(Top) the overall proposed structure of WSSV virion.  
(Bottom) The average size of the WSSV nucleocapsid encapsidated within the double-
layered envelope is 80×350 nm. There are 15 distinct and spiral helices along its long 
axis. Each spiral helix has two striations composed of seven pairs of globular capsomers, 
each of which is 8 nm in diameter. The spacing between each spiral helix is 7 nm. A 
‘ring-like’ structure is associated at one terminus of the nucleocapsid core. (Huang et al. 
2001) 
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1.1.3 The Genome Structure of WSSV 
 
The complete genome sequence of three different isolates of WSSV has been 
published (van Hulten et al. 2001a; Yang et al. 2001; Chen et al. 2002a) (Genebank 
Accession Nos. AF332093, AF369029, AF440570 for viruses isolated from China, 
Thailand and Taiwan, respectively). WSSV is the first marine invertebrate virus that has 
its genome completely sequenced and it is also at present the largest animal virus whose 
complete genome has been sequenced.  
 
The complete WSSV genome is a double-stranded circular DNA of 305,107 bp, 
very close to the previous estimate of 290 kb (Yang et al. 1997). Since the origin of 
replication was unknown, the start of the largest BamHI fragment was chosen to be base 
1. Three percent of the WSSV genome is made up of nine homologous regions (hrs), 
while the remaining 97% of the sequences are unique (see description below). The 
genome has a total G+C content of 41% that are uniformly distributed (Yang et al. 2001).  
 
A total of 531 putative open reading frames (ORFs) were identified by sequence 
analysis, among which 181 ORFs encoding more than 50 amino acids are likely for 
functional proteins. This corresponds to an average gene density of one gene per 1.7kb. 
The relative positions of the ORFs and homologous regions (hrs) in the genome are 
shown in Figure 1.6. There is a potential polyadenylation site (AATAAA) downstream of 
the ORFs for 80% of the 181 putative ORFs. The putative proteins encoded by 18 ORFs 







Figure 1.6  Circular representation of the WSSV genome  
 
Arrows, positions (outer ring) of 181 ORFs (red and blue indicate the different directions 
of transcription); green rectangles, 9 homologous regions (HRs).  
B, sites of BamHI restriction enzymes (inner ring; their positions are indicated in 




an identifiable functional domain. These proteins include enzymes involved in nucleic 
acid metabolism and DNA replication, a collagen-like protein, and three viral structural 
proteins. Proteins predicted from thirty ORFs also show partial homology (20 to 39% 
identity) to known proteins or contain one or two sequence motifs (versus a real 
functional domain). However, the remaining 133 ORFs encode novel proteins with no 
homology to any known proteins or motifs (Yang et al. 2001). 
   
The most unique feature of WSSV is the presence of an collagen gene, a gene 
encodes an extracellular matrix protein of animal cells that has never been found in any 
other viruses (Yang et al. 2001). The genome information provides us the molecular basis 
of viral replication and infection. 
 
The analysis of the genome showed that WSSV differs from all known viruses, 
suggesting that it represents a novel class of viruses and perhaps implying a significant 
evolutionary distance between marine and terrestrial viruses. The next section will 
introduce studies on the taxonomy of WSSV during the past decades. 
 
 
1.1.4 Taxonomy of WSSV 
 
WSSV was classified in the Baculoviridae family and the subfamily of the non-
occluded baculoviruses with its rod-shaped and enveloped morphology that are similar to 
insect baculovirus (Francki et al. 1991). However, more in-depth studies on the general 
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and molecular characteristics of WSSV (Inouye et al. 1994; Momoyama et al. 1994; 
Wongteerasupaya et al. 1995; Lo et al. 1997) and analysis of the complete genome 
sequence (van Hulten et al. 2001a; Yang et al. 2001; Chen et al. 2002a) suggest that 
WSSV is not related to any virus of the Baculoviridae family or any other family of 
viruses. Looking at the phylogenetic tree of the genes for WSSV DNA polymerase 
(Figure 1.7), ribonucleotide reductase large (rr1) and small (rr2) subunits, protein kinase, 
thymidine-thymidylate kinase and endonuclease, no obvious relationship was revealed 
between WSSV and other established family of large dsDNA virus (Chen et al. 2002b).  
 
  Based on the uniqueness of WSSV, many scientists have suggested that it should 
be excluded from the Baculovirus family and be classified as a new virus family. 
Recently, the International Committee on Taxonomy of Viruses approved a proposal to 
elect WSSV as the type species of the genus Whispovirus, family Nimaviridae 
(www.ncbi.nlm.nih.gov/ICTVdb/Ictv/index.htm). The family name reflects the most 
notable physical feature of the virus, the tail-like projection extending from one end of 
the WSSV virion. The uniqueness of WSSV has attracted extensive research into its 
evolution and infection mechanism. In the protein level, most researches are focused on 
the envelope proteins that play important roles in the infection and maturation 














Figure 1.7  Bootstrap analysis (100 replicates) of an uprooted phylogenetic tree of the 
DNA polymerase from WSSV. 
 
The numbers at the branches indicate frequency of the clusters and frequencies over 70% 





1.1.5 Envelope Proteins of WSSV 
 
In general, viral proteins are divided into three temporal classes: early proteins 
synthesized prior to the replication of the DNA, the intermediate and late proteins 
synthesized after the onset of DNA replication (Jensen et al. 1996). The late proteins that 
synthesized from 5 to 6 hours after infection are assumed to be virion-associated proteins. 
In characterizing any virus, its virion-associated proteins are particularly important for 
understanding the mechanisms of viral infection and morphogenesis. 
   
A virion is a complex assembly of macromolecules exquisitely suited for the 
protection and delivery of viral genomes (Tsai et al. 2006). As a double-layer enveloped 
virus, virion-associated proteins of WSSV include proteins of both the envelope and 
nucleocapsid. Thirty nine virion-associated proteins have been identified due to the gel 
based  mass spectrometry techniques (Huang et al. 2002a; Huang et al. 2002b; Li et al. 
2004; Tsai et al. 2004). Shotgun proteomic studies have identified fifty five virion-
associated proteins in our laboratory recently (Li et al, unpublished data).  
 
Among these virion-associated proteins, the envelope proteins are of extremely 
importance because they are believed to be the first molecules to interact with the host 
and hence play critical roles in targeting the host cell and triggering host defenses.  
Determining the localization of structural proteins in the virion is important to elucidate 
their roles in both virus assembly and infection. Up to date, four major envelope proteins 
(VP19, VP24, VP26 and VP28) and several minor envelope proteins (VP31, VP39, 
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VP124, VP187, VP281, VP292, VP466) were detected by Western blotting technique 
and localization study under electron microscope (Huang et al. 2002a; Huang et al. 2002b; 
Zhang et al. 2002a; Zhang et al. 2002b; Zhang et al. 2004; Li et al. 2005b; Li et al. 2006; 
Xie et al. 2006; Zhu et al. 2006).  
 
There are different classes of membranes proteins: Integral proteins interact with 
hydrophobic parts of the bilayer’s phospholipids, and they are not easy to remove. Most 
span the bilayer, with their hydrophilic domains extending past both of its surfaces. 
Peripheral proteins are positioned at the membrane surface, not in the bilayer. Weak 
interactions, including hydrogen bonds, allow them to associate with integral proteins and 
with polar heads of the membrane lipids. For major envelope proteins of WSSV such as 
VP26 and VP28, they both have a hydrophobic transmembrane domain that serves to 
anchor them to the surface of the lipid bilayer.  
 
Using SDS-PAGE profiles of envelope fractions from WSSV, VP19, VP24, VP26 
and VP28 have been shown to constitute the major part of the entire envelope. 
Interestingly, there are striking similarities between VP24, VP26 and VP28 at the amino 
acid and the nucleotide sequence level. VP26 and VP28 share a sequence similarity of 
41%, whereas VP24 shares significant sequence similarities of 41% and 46% with VP26 
and VP28 respectively. These three proteins have the same size (~ 206 aa) and all are 
predicted to have a transmembrane region of approximately 30 amino acid in length at 
the N-terminus. This strongly suggests that the genes of these three envelope protein may 
have evloved by gene duplication. Another major envelope protein, VP19, has no 
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sequence homology with other WSSV or other known viral proteins. The transmembrane 
region of VP19 is predicted to be situated at the middle of the protein sequence.  
 
As far as functional study is concerned, VP28, VP68, VP281, and VP466 were 
believed to play an important role in the systemic WSSV infection in shrimp by using an 
in vivo neutralization assay (van Hulten et al. 2001b; Li et al. 2005a; Xu et al. 2005). 
VP28 is often used for detecting the WSSV in crustaceans because of its abundance in 
the proteins profile (Yoganandhan et al. 2004). VP26 is reported to be capable of binding 
to actin or actin-associated proteins (Xie and Yang 2005). Another envelope protein, 
VP281, which contains a cell attachment RGD motif, is also supposed to play an 














1.1.6 Problems Faced in Study of Envelope Proteins of WSSV 
 
Envelope proteins have been investigated extensively because of their importance 
in viral infection and this project will also focus on the characterization of these envelope 
proteins. There are, however, many well-known technical difficulties that hinder in-depth 
studies to elucidate the function of the envelope proteins from WSSV. The lack of 
established shrimp cell lines for in vitro reproduction of WSSV is one of the major 
obstacles. The function of these envelope proteins are also hard to predict because of 
their lack of homology with other known proteins. Therefore, we will utilize structural 
genomics approaches to elucidate the structure of the WSSV proteins to understand their 
function towards the drug design. 
 
Among the 55 structural proteins identified by mass spectrometry, 11 and 3 of 
them have been assigned as the envelope and the nucleocapsid proteins respectively. The 
localizations of the other 40 structural proteins are still unknown. At present, only VP28 
has been confirmed to be involved in the attachment and penetration of the WSSV into 
shrimp cells (Yi et al. 2004). The roles of other envelope proteins in the life cycle of the 
virus remain to be defined. Moreover, up to now, tertiary structures are not available for 
any WSSV proteins. This project will therefore focus on the characterization and 





1.2 Structural Genomics 
 
1.2.1 Structural Genomics as a New Research Initiative 
 
New research initiatives in biology are being driven by complete sequencing of 
the genomes from various organisms (Green 2001; Lander et al. 2001; Aparicio et al. 
2002; Yu et al. 2002), which gave us the protein repertoires of diverse organisms from all 
kingdoms (Marsden et al. 2006). The genome-sequence projects have accumulated lots of 
sequence data providing us nearly complete lists of macromolecules present in an 
organism. However, the knowledge of the components relatively little about the function 
and organization of biological systems (Bravo and Aloy 2006). The challenge to 
understand these gene products has led to the development of functional genomics 
approaches, which collectively aim to improve the biological understanding of the 
genetic sequence. Structural genomics is one of such approaches, with an unique promise 
to reveal the molecular function of protein domains (Ashburner et al. 2000). A good 
understanding of molecular functions & interactions can come from high-resolution 
three-dimensional (3D) structures, as they provide key atomic details on the binding 
surfaces. Structural genomics projects, together with computational structure prediction 
methods (Bradley et al. 2005), are likely to provide 3D structures for most of the proteins 
within an organism. 
 
Worldwide structural genomics initiatives, advanced by the development of 
improved technologies in X-ray crystallography and NMR, are expanding our knowledge 
on structural families with increasing number of novel protein folds. Methods for 
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detecting remote sequence similarities have also been improved in sensitivity and enabled 
us to map domains from these structural families onto genome sequences directly to 
understand how these families are distributed throughout the genomes. This in turn reveal 
how these proteins might influence the functional repertoires and biological complexities 
of the organisms (Marsden et al. 2006). 
 
 
1.2.2 WSSV as a Model for Structural Genomics Study 
 
WSSV provides an important and interesting model for structural genomics study. 
It has a relatively small genome with only about 181 open reading frames, much smaller 
than herpes virus and other viruses with large genomes. Many of the WSSV putative 
ORFs do not have match with any known proteins and functions. Structural genomics 
therefore offers an opportunity to elucidate the function of these proteins through 
structure determination and prediction. Structure elucidation of WSSV will provide 
insights on the mechanisms of host-pathogen interaction, the maturation and assembly of 
the virus particles and many other important biological processes. More importantly, it 







1.3 X-ray Crystallography 
 
1.3.1  Overview 
 
It is necessary to know the precise arrangement of atoms in biological 
macromolecules in order to understand how they function at the molecular level. In 
addition, this information is required for the rational design of drugs that target a specific 
activity of the molecule or prevent the molecule from binding to other molecules with 
which it normally interacts (Yaffe 2005). X-ray crystallography is one of the most 
powerful techniques that are used to obtain atomic information about molecular structure. 
 
In brief, structure determination of a protein by X-ray crystallography requires the 
growth of high-quality crystals from the purified protein, measurement of the directions 
and intensities of X-ray beams diffracted from the crystals, and the use of a computer to 
calculate the electron density map after the phase problem is being solved. Finally, the 
protein backbone is fitted into the electron density map and refined to give the structure 
coordinates (Rhodes 2000).  
 
In Figure 1.8, the synopsis of structure determination by X-ray crystallography is 
clearly shown. The macromolecule of interest is crystallized, and a single crystal that 
contains thousands of copies of the macromolecule is placed in an X-ray beam. The 
crystal is slowly rotated in the X-ray beam and diffraction patterns similar to the one 











Figure 1.8 Synopsis of structure determination by X-ray crystallography  
 
The macromolecule of interest is crystallized, and a single crystal containing thousands 
of copies of the macromolecule is placed into an X-ray beam. The crystal is slowly 
rotated in the X-ray beam and diffraction images similar to the one shown are collected 
every 0.5–1 degree of rotation until all points in the crystal have been sampled. The 
intensity of the diffracted X-ray, together with information about their phases, is collected 
and converted by a Fourier transforming to an electron density map of the protein. A 




reciprocal space have been sampled. Structure determination of a molecule requires 
knowing both the amplitude and the phase of the photon wave being diffracted from the 
crystalline sample. Although a detector can measure the intensity of a wave, which is 
proportional to its amplitude, there is no way to measure its phase. The phase angel is the 
difference of the angles between the combined X-ray scattered by all atoms of this 
molecule and the original X-ray. Thus, it is common to hear that one has "lost the phase" 
when measuring a diffraction pattern. Reconstructing the phase of the diffracted wave is 
the crux of the phase problem. The intensity of the diffracted X-ray, together with 
information about their phases, is converted by Fourier transformation into an electron 
density map of the protein. A model of the protein structure is then built into the electron 





X-ray crystallography is totally dependent on highly ordered crystals. Obtaining 
such crystals is the rate-limiting step in structure determination and the pressure is to 
produce crystals. As a result, the science of crystallization is gathering a new momentum 
and is becoming a rapidly developing field (Chayen 2004).  
 
Crystallization is a phase transition phenomenon. Crystals grow from an aqueous 
protein solution when the solution is brought into supersaturation (Ataka 1993; Ducruix 
and Giege 1999; McPherson 1999). Supersaturation is achieved by varying the 
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concentration of precipitant, protein and additives, pH, temperature and other parameters. 
The task to produce suitable crystals can be tackled using two different approaches. The 
first relies on empirical techniques that is based mainly on trial and error, and what is 
perceived to be the “art” of crystallization. The second approach is aimed at gaining an 
understanding of the fundamental principles that govern crystallization; this knowledge 
may be applied to design experimental methodology for producing high-quality crystals 
of medical and industrial interest (Chayen 2004). 
 
The past few years have seen some of the greatest achievements in the field of 
protein crystallization e.g. automation and miniaturization of  crystallization trials (Kuhn 
et al. 2002; Walter et al. 2005). The high-throughput approach has reduced the time 
needed to set up a series of experiments. The subsequent phases of different pattern 
capture and analysis of the data is also progressing at high speed (Luft et al. 2003). 
However, the high-throughput has not led to high output. Production of suitable crystals 
still remains as a rate-limiting step. It is still not understood why some proteins crystallize 
easily while others stubbornly refuse to produce suitable crystals. Obviously there is an 
urgent need to solve the problem by a more systematic & scientific approach (Chayen 
2004). 
   
The success rate to obtain high-quality crystals is improving rapidly and it will 
improve further as we progress to the more sophisticated techniques, which will play a 
major role in crystallization and structural biology. 
 
  26
1.3.3 X-ray Diffraction 
 
X-ray is an electromagnetic radiation with wavelengths in the range from 0.1 to 
1000 Å. X-ray rays are generated when electrons (or other charged particles) undergo 
severe acceleration (or deceleration). There are two types of X-ray sources used for 
macromolecular crystallography, those from rotating anode and the synchrotron radiation.  
 
The rotating anode type X-ray generator is the laboratory scale sources. An anode 
of appropriate target metal (copper, molybdenum etc.), a cathode and a tungsten filament 
are kept inside an evacuated tube. When a high voltage difference is maintained between 
the anode and cathode, electrons, produced by the filament by thermionic emission, hit 
the anode and X-rays are produced. Depending on the target and transition, the radiation 
is named as Cu Kα, Cu Kβ etc. The anode is rotated by a motor for efficient distribution 
and dissipation of heat and a high intensity beam is produced. The X-rays produced at the 
impact point are distributed over a wide angular range and cover a wide range of energies 
up to a maximum energy determined by the voltage at which the tube is operated. In a 
synchrotron, electrons travel in a storage ring at a high speed and are emitted as radiation 
and it is possible to change the wavelength of synchrotron radiation. Here bunches of 
very high energy electrons (several GeV) move in a closed loop. At each bending point 
an intense and very narrowly defined pencil beam of radiation is emitted. The beam 
contains radiation of a wide range of energies - UV through to X-rays. Synchrotrons are 
very large central facilities that have their own operating procedures and safety systems 
that visitors and users must follow. 
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1.3.4 Structure Determination 
 
To determine the structure of a protein means that position of all atoms of the 
protein in the unitcell represented by the electron density map are known. There is a 
direct relationship between the electron density map of the unitcell and the structure 
factors of the diffraction pattern as related by the Fourier transformation. However, in 
order to calculate the electron density map of the unitcell, one needs the experimental 
structure amplitudes and their phase angles.  
 
As the phase angle is an immeasurable quantity, the information can only be 
derived by one of the following methods. In the molecular replacement (MR) method, an 
available similar structure is used as a model to probe the experimental data to identify 
the structure of interest.  Direct methods are based on the positivity and atomicity of 
electron density that leads to phase relationships between structure factors. The phase 
angle is obtained by mathematical means. In the multiple isomorphous replacement (MIR) 
method, the data set for a native crystal and data sets for two derivative crystals, obtained 
by soaking the native crystal in two different heavy metal containing solutions, are 
collected. In the multiwavelength anomalous dispersion method (MAD), a crystal 
containing an anomalously diffracting atom is used for data collection at three different 
wavelengths using a synchrotron. Positions of these anomalous atoms are first 
determined and the electron density map is made. SAD (single-wavelength anomalous 
diffraction) method is becoming increasingly possible to collect data at just a single 
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wavelength, typically at the absorption peak, and use density-modification protocols to 
break the phase ambiguity and provide interpretable maps.  
 
The electron density map is calculated after the phase problem is being solved. 
The protein model is refined until the difference between the experimental and calculated 
(using the model) structure factors (R-factor) reaches at an acceptable minimum. The 
most used refinement program is “CNS” (Crystallographic and NMR System). CNS 
adopts the algorithm of energy minimization for the refinement 
 
 
1.4 Objectives of the Project 
 
The characterization of viral structural proteins especially the envelope proteins is 
of significant importance to study the virus taxonomy, infection assembly. Due to the 
lack of a shrimp cell line for in vitro reproduction of this virus and low homology with 
other proteins of known function, we have decided to take a structural proteomics 
approach to study the envelope proteins of WSSV. The objectives of this project are: 
1) To identify more envelope proteins of WSSV. Among the 55 structural proteins 
identified by mass spectrometry, only 11 have been assigned as envelope proteins and 3 
as nucleocapsid proteins. There are 40 structural proteins unassigned. We will use 
western blotting and immuno-gold-labeling electron microscopy to study the localization 
of these envelope proteins. Neutralization assay that can determine whether the envelope 
proteins are involved in the virus entry during infection will also be performed. 
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2) To elucidate the three dimensional structure of the viral envelope proteins. The 
study attempts to determine the structures of these envelope proteins to understand their 
function towards the drug design. 
 
 
1.5 Significance of the Project 
 
Once the 3D structures of major envelope proteins are solved, their structural 
features should provide us an unique opportunity to postulate the function of these 
envelope proteins. Also, the structure of these envelope proteins and their interactions 
explain the unique morphological features of WSSV. The structural elucidation of WSSV 
envelope proteins will provide us much useful information for further research on host-
virus interaction, the maturation and assembly of the virus particles and many other 
important questions. It will also help us to better understand the infection mechanism and 
life cycle of WSSV. Finally, it will provide a wealth of information for structure based 
drug design that can be used to develop specific inhibitors to control or even prevent the 
outbreak of WSSV. 
 
1.6 Scope of the Thesis 
 
X-ray crystallography techniques will be used to determine the structures of the 
envelope proteins. The major envelope proteins like VP19, VP24, VP26 and VP28 are the 














2 Materials and Methods  
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2.1 Bacterial Strains, Vectors, Primers and Bacterial Culture 
 
Bacterial Strain DH5α (Invitrogen) was used in this study as host for cloning 
experiments and BL21 Star (DE3) strain (Invitrogen) for protein expression. Vector 
pGEX6p-1 (Amersham Bioscience) was used for GST fusion protein expression and 
pET32a(+) (Novagen) for His-tag protein expression. Escherichia coli starins were 
grown at 37 °C in LB (Luria broth) liquid media (10g Tryptone, 5g yeast extract, 10g 
NaCl, pH7.5) or 1.5 % agar medium (Sambrook and Russell 2001). For long-term storage, 
all bacterial strains were stored in LB with 50% glycerol at -80 °C freezer.  
The sequences of some primers used in this study are shown as following: 
N-terminus truncated VP28 (residues 31-204) 
  CGC GGA TCC AAC ACT GTG ACC AGG ACC ATC GAA 
  CCG GAA TTC TTA CTC GGT CTC AGT GCC AGA 
N-terminus truncated VP26 (residues 35-204) 
  CGC GGA TCC ATG AAC ACA CGT GTT GGA AGA 
  CCG GAA TTC TTA CTT CTT CTT GAT TTC GTC CTT 
Full-length VP300 
  CGC GGA TCC ATG GGA GAT AAG CAA AAG GTG GAA 
  CGC GAA TTC TTA GGA GCA TGT GCA TGT GAT CCT  
Full-length VP281  
  CGC GGA TCC ATG GCG GTA AAC TTG GAT AAT 
  CGC GAA TTC TTA TGT CCA ACA ATT TAA AAA GAA  
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2.2 DNA Manipulation 
 
DNA manipulations were carried out following standard molecular protocols 
cited from Molecular Cloning (Sambrook and Russell 2001) with some modifications. 
 
2.2.1 Amplification of DNA by Polymerase Chain Reaction (PCR) 
 
DNA fragments and related genes were amplified by the basic polymerase chain 
reaction (PCR). High fidelity Pfu DNA polymerase (Promega) was used to amplify the 
genes from WSSV genomic DNA. The composition of PCR reaction mixture was shown 
as following: 5 µl 10 × PCR buffer (without MgCl2), 5 µl MgCl2 (25 mM), 1 µl 5’ Primer, 
1 µl 3’ Primer, 1 µ dNTPs (25 mM) l, 1 µl Template DNA (20-100 ng/ µl), 1 µl Tag DNA 
polymerase (1 unit/ µl), and distilled water to a final volume of 50 µl.   
The PCR was run on an iCycler Thermal Cycler (Bio-rad) with the following 
program. 1 cycle of 95 °C for 1 ~ 2 minutes, 30 cycles of each at 95 °C for 30 seconds, 
50 °C for 30 seconds and 72 °C for 1 minute per 1kb DNA, and 1 cycle of 72 °C for 15 
minutes.   
 
2.2.2 DNA Digestion and Ligation 
 
DNA digestion and ligation were conducted according to the instruction manual 
by the supplier. The DNA digestion mixture comprised of 10 µl DNA, 1 µl restriction 
enzymes, 2 µl 10×BSA, 2 µl reaction buffer and 4 µl sterile H2O. The mixture was 
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incubated at 37 °C for 2 hours. For single-digestion vectors, dephosphorylation is 
required for the subsequent ligation. In this case, the vector mixture was treated 
additionally with alkaline phophatase (Promega) at 37 °C for 1 hour,  followed by 
inactivation of the alkaline phophatase at 75 °C for 10 minutes. The digested DNA 
products were further purified using agarose gel electrophoresis and QIAquick Gel 
Extraction Kit (QIAGEN). Bacteriophage T4 DNA ligase was used to ligate the digested 
DNA fragments to the digested vectors. The ligation was performed at room temperature 
for 3 ~ 4 hours or at 4 °C for overnight. 
 
2.2.3 Agarose Gel Electrophoresis and DNA Purification 
 
DNA fragments were separated by agarose gel electrophoresis in TAE buffer 
(0.04M Tris-acetate, 0.001 M EDTA, pH 8.0) along with a standard DNA ladder 
(Fermentas). Normally, the concentration of agarose gel is 1% and ethidium bromide (EB) 
was directly added to the agarose gel to a final concentration of 0.5 µg/ml. The separated 
DNA fragments were recovered from the agarose gel by using the QIAquick Gel 
Extraction Kit (QIAGEN) according to the manufacturer’s instructions. 
 
2.2.4 Preparation of E.coli Competent Cells 
 
Highly efficient competent cells of E. coli DH5α and BL21 (DE3) strains were 
prepared by the rubidium chloride method. Freshly growing E. coli colonies from LB 
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agar plates were inoculated into 100 ml of Psi broth medium (5g yeast extract, 20g 
tryptone, 5g magnesium sulfate, pH7.6) in a 1-liter conical flask and then allowed to 
grow at 37 °C with vigorous shaking (200 rpm). After the cells grew to an OD550 of 
0.45~0.5, the culture was chilled on ice for 15 min and then the cells were collected by 
centrifugation at 5,000 rpm (Beckman J2-21 ) for 5 min at 4 °C. The cell pellet was 
resuspended in 40 ml of ice-cold TfbI buffer (30 mM potassium acetate, 100 mM 
rubidium chloride, 10 mM CaCl2, 50 mM MgCl2, 15% v/v glycerol, pH 5.8) and 
incubated on ice for 15 min. After centrifugation, the cell pellet was resuspended by 4 ml 
TfbII buffer (10 mM MOPS, 10 mM rubidium chloride, 75 mM CaCl2, 15% v/v glycerol, 
pH 6.5). The competent cells can be either used immediately or quickly frozen as 0.25 ~ 
0.5 ml aliquots in liquid nitrogen prior to storage in a -80 °C freezer. 
(http://130.15.90.245/e__coli_competent_cells.htm)  
 
2.2.5 Transformation of Bacterial Cells 
 
In most operations, DNA was transferred into E. coli cells by heat-shock 
following the standard protocol (Sambrook and Russell 2001). Frozen competent cells 
(50 µl) were thawed on ice. The transforming DNA (up to 25 ng per 50 µl of competent 
cells), including plasmid or ligation product, was added to the competent cell suspension 
in a volume not exceeding 5 % of that of the competent cells. The competent cells were 
mixed with the transforming DNA by swirling gently and then incubated on ice for 30 
minutes. The mixture of cells and DNA were heat-shocked at 42 °C for 1 minute and 
immediately chilled on ice for 2 min. Eight hundred microliters of fresh LB medium were 
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added to the transformed cells. The transformed cells were incubated at 37 °C for 45 min 
with shaking to allow the bacteria to recover and to express the antibiotic resistance 
marker encoded by the plasmid vector. The cells were collected by centrifugation and 
spread onto LB agar plates containing the appropriate antibiotic. Colonies usually 
appeared after overnight incubation at 37 °C. 
 
2.2.6 DNA Sequencing 
 
The sequencing PCR run mixture was 10 µl and contained: 2 µl BigDyeTM Ready 
Mix (v 3.0), 0.5 µl primer, 2 µl template DNA (purified plasmids or PCR products, 
100~200 ng µl-1) and 5.5 µl deionized water. The sequencing cycle was normally 
performed using the following program: 1 cycle at 96 °C for 0.5 ~ 1 min and then 25 
cycles each at 96 °C for 15 seconds, annealing at 50 °C for 15 seconds and extension at 
60 °C for 4 min. The sequence product was kept at 4 °C until ready to purify. After the 
cycle sequencing was finished, the contents in the PCR tube were spun down and then 
transferred into a clear 1.5-ml tube. 80 µl of acetate-ethanol mixture (3 µl of 3M sodium 
acetate, 62.5 µl 95% ethanol and 14.5 µl water) was added to the tube. The contents in 
the tube were mixed by vortexing and the tube was allowed to stand at room temperature 
for 15 minutes to precipitate the extension products. The pellet was collected by 
centrifugation at 14,000 rpm (Eppendorf 5417C) for 20 min and then washed twice with 
70% ethanol before centrifugation at 14,000 rpm (Eppendorf 5417C) for 10 min. After 
the supernatant was carefully aspirated from the tube, the pellet was dried and stored at –
20 °C. This pellet is ready to be submitted for running electrophoresis. 
  36
2.3 Virus Treatment and Analysis 
 
2.3.1 Virus Propagation and Purification 
 
The WSSV isolate used in this study was originated from WSSV infected 
Penaeus chinensis (Ningbo, China) and was propagated in an alternate host, red claw 
crayfish, Cherax quadricarinatus. Preparation of WSSV virions was carried out based on 
the method described previously (Huang et al. 2001) with some modifications. The 
haemolymph collected from infected crayfish were diluted in PBS buffer and stored in -
80 oC as the stock. One tube of the stock haemolymph was thawed and after 
centrifugation at 1000 × g for 10 minutes, the supernatant was filtered (0.45 µm filter) 
and diluted 10 times in PBS buffer as the virus inoculum. Then we injected 0.3-0.4ml of 
the virus inoculant was injected intramuscularly into the healthy red claw crayfish in the 
lateral area of the fourth abdominal segment. After four to five days later, hemolymph 
freshly extracted from moribund crayfish was first centrifuged at 2,000 × g to get rid of 
the tissue debris. The supernatant was layered on the top of a 30 – 60% (w/v) stepwise 
sucrose gradient and centrifuged at 20,000 rpm using a SW28 rotor in a Beckman 
ultracentrifuge (XL-90; Beckman Coulter) for 2 hours at 4°C. Virus bands (Figure 2.1) 
were collected and then diluted two or three times with TN buffer (20mM Tris-HCl and 
400mM NaCl, pH7.4) before centrifugation again at 20,000 rpm using a SW28 rotor for 1 
hour. The pellets were washed with TN buffer followed by a centrifuge at 12,000 × g for 
30 minutes at 4 °C. The wash step was repeated to remove all the sucrose. The resulting 



















Figure 2.1 Banding of purified WSSV Virus in the sucrose gradient 
 
The stepwise sucrose gradient used was 30%, 40%, 50%, 60% (w/v) from the top. The 
virus band showed in the interface between 40% and 50% gradient after 





2.3.2 Treatment of the Intact Virus with Detergent 
 
The virus envelope was separated from the virus particles by treatment with Triton 
X-100. Generally, the purified WSSV was mixed with an equal volume of 0.2% Triton 
X-100 and incubated for 1 h at room temperature. The nucleocapsids were purified by 
centrifugation at 20,000 × g for 20 min at 4 °C. The envelope fraction was collected in 
the supernatant. The nucleocapsid fraction was subjected to a second round of Triton X-
100 extraction to ensure the envelopes were removed completely. The degree of purity of 
the intact virions isolated and the nucleocapsid fractions were evaluated by negative-
staining transmission electron microscopy. 
 
2.3.3 Preparation of WSSV Genomic DNA 
 
WSSV genomic DNA from gradient-purified virions was extracted by protease K 
and cetyltrimethylammonium bromide (CTAB) treatments, followed by phenol-
chloroform extraction and ethanol precipitation (Lo et al. 1996). Briefly, protease K and 
N-laurysarcosine were added to the purified viral particles suspended in TNE buffer to a 
final concentration of 0.5 mg/ml and 0.5%, respectively. After 1 hour incubation at 65 °C, 
the solution was then treated with 1% CTAB for 15 minutes at 65 °C. This was followed 
by successive extractions with an equal volume of phenol once, an equal volume of 
phenol:chloroform:isoamyl alcohol (25:24:1) for 3 ~ 4 times, and then an equal volume 
of chloroform:isoamyl alcohol once. Viral DNA was recovered by ethanol precipitation, 
dried and dissolved in a small volume of 0.1 × TE buffer (50 mM Tris, 1 mM EDTA,  
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 pH 8.0) containing RNAse A (10ug/ml) before quantified by spectrophotometry with the 
Shimadzu spectrophotometer (Model UV-300). 
 
2.3.4 Transmission Electron Microscopy 
 
For transmission electron microscopy (TEM) examination, virus samples were 
deposited onto formvar-coated, carbon-stabilized copper grids (200-mesh, Electron 
Microscopy Sciences) before they were negatively stained with 2% (w/v) sodium 
phosphotungastate (PTA, pH 7.0). The grids were dried and examined under electron 
microscope (JEOL JEM 2010F or PHILIPS CM 10).  
 
2.3.5 Localization Study by Immunoelectron Microscopy 
 
WSSV intact virion and nuclocapsid suspension were mounted on carbon-coated 
nickel grids (300 meshs, Electron Microscopy Sciences) and kept for 5 minutes before 
blocking in 5% BSA (in 20 mM phosphate buffer) for 30 minutes at room temperature. 
The first antibody (diluted with 5% BSA buffer, concentration of 40 mg/ml) was added 
and kept at 4°C overnight. After washing at least three times for 10 minutes, the gold 
labeled second antibody (goat-anti-mouse/rabbit IgG, 1:40 dilution, Electron Microscopy 
Sciences) was added and incubated for 2 ~3 hour at room temperature. The grids were 
washed by 5% BSA buffer twice and followed by water once. Negative stain by 2% PTA 
was performed for 2 ~3 minutes and the grids were dried before examining under TEM.   
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2.4 Protein Manipulation 
 
 
2.4.1 Protein Expression and Solubility Test 
 
The constructs encoding WSSV envelope proteins were introduced into E. coli. 
The bacterial cells were grown to a concentration of approximately OD600 = 0.5 ~ 0.6 at 
37 °C. IPTG was added to the cultures in a final concentration of 0.1 mM to induce the 
expression of fusion proteins. The bacterial cultures were allowed to grow for additional 
5 ~6 hours at 25 °C or overnight at 18°C. All the subsequent operations were performed 
at 4 °C. The cells from 500 ml of culture were harvested by centrifugation and 
resuspended in 25 ml lysis buffer (20 mM Tris, 500 mM NaCl; 10 mM EDTA, 2mM 
DTT, 100 µM PMSF, 5% Glycerol, pH 8.0). After treatment with chicken egg lysozyme 
(final concentration of 1 mg/ml) for 30 minutes, the cell suspension was sonicated to near 
clarity and centrifuged at 20,000 rpm for 1 hour using a J6-HC centrifuge (Beckman 
Coulter). The supernatant and pellets sample were loaded into SDS-PAGE to determine 
the solubility of the fusion proteins expressed. 
 
2.4.2 Expression of Seleno-Methionine Substituted Protein 
 
The selenomethionine substituted protein was expressed in defined LeMaster 
medium using the methionine auxotrophic strain (DL41). The LeMaster medium amino 
acid mixture for 1L medium were prepared as following: 0.5 g Alanin, 0.58 g 
Arginine.HCL, 0.4 g Aspartic acid, 0.03 g Cystine, 0.67 g Glutamic acid, 0.33 g 
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Glutamine, 0.54 g Glycine, 0.06 g Histidine, 0.23 g Isoleucine, 0.23 g Leucine, 0.42 g 
Lysine.HCL, 0.13 g Phenylalanine, 0.1 g Proline, 2.08 g Serine, 0.23 g Valine, 0.5 g 
Adenine, 0.67 g Adenine, 0.67 g Guanosine, 0.17 g Thymine, 0.5 g Uracil, 1.5 g Sodium 
acetate, 1.5 g Succinic acid, 0.75 g Ammonium chloride,  1.08 g Sodium hydroxide, 10.5 
g Dibasic K2HPO4. This autoclaved mixture should be stored dry at -20°C.  
 
Dissolve 24.1 g of the amino acid mixture to 1 Liter of deionized water and 
autoclave for 20 minutes. Dissolve 10 g D-glucose, 0.25 g MgSO4.7H2O and 4.18 mg 
FeSO4.7H2O in 90ml deionized water. 8.3 µl of concentrated H2SO4 and 10 ml Kao and 
Michayluk vitamen solution (Sigma) were added and filter sterilize. All these are added 
into the above autoclaved medium. Add 25 mg L-selenomethionine (Sigma) and 1 ml 0.1 
g/ml amipicillin immdediately prior to inoculation. Inoculate the methionine auxotrophic 
strain (DL41) containing the plasmid of interest in defined LeMaster medium and grow at 
37 °C until the reading of OD600 is above 0.6. IPTG was then added into the culture 
medium for the protein over expression. 
 
2.4.3 GST fusion Protein Purification and Removal of GST tag 
 
All the subsequent operations were performed at 4 °C. The soluble fusion proteins 
were present in the supernatant of cell lysate from above steps. The supernatant was 
filtered through 0.45 µm filter (Millpore) and loaded onto a Glutathione Sepharose 4B 
column (Amersham Biosciences), followed by washing with at least 10 column volume 
of lysis buffer. The protein was eluted with 20 mM reduced glutathione freshly prepared 
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in lysis buffer. The concentration of eluted GST fusion protein was determined with 
Coomassie Protein Assay kit (Pierce) according to the manufacturer’s instructions. 
ProScission™ protease (Amersham Biosciences) was added to the eluted protein solution 
and kept at 4°C overnight for reaction. After digestion, the solution was loaded onto a 
HiPrep Desalting column (Amersham Biosciences) with the desalting buffer (20 mM Tris, 
100 mM NaCl, 2 mM DTT, pH8.0) to get rid of the reduced glutathione. After desalting, 
the protein solution was passed through the Glutathione Sepharose 4B column to remove 
the GST cleaved away from the fusion protein. 
 
2.4.4 Purification of Untagged Protein 
 
After removal of GST, the solution of untagged protein was further purified by 
Superdex 75 size exclusion chromatography (Amersham Biosciences) using gel filtration 
buffer. The purified protein fractions were collected and concentrated to a final 
concentration of 8 mg/ml with a VIVASPIN 20 (Vivascience) concentrator. The purity of 
the protein was examined by SDS-PAGE as well as by native gel electrophoresis. 
 
2.4.5 Antibody Preparation 
 
To obtain the polyclonal anti-rabbit antibody, New Zealand wild type female 
rabbits were used in this study. A small amount (about 5 ml) of preimmune blood was 
drawn from each rabbit prior to any injections as negative controls. 0.5 ml of purified 
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protein (0.1 mg) was mixed and emulsified with an equal volume of complete Freund’s 
Adjuvant. The freshly prepared emulsion was immediately injected into one limb of the 
rabbit. The first boost was done four weeks later on another limb. The dosage for each 
booster was 50 µg, which was emulsified in 0.5 ml of Incomplete Freund’s Adjuvant 
(IFA) emulsion and injected into another limb. After the first booster, the rabbit was 
injected every week and the limbs were used in rotation during the subsequent boost 
injections. 
   
To obtain the polyclonal anti-mouse antibody, the purified protein was used to 
immunize 3- to 4- week-old Swiss Albino mice once every 2 weeks by intradermal 
injection over an 8-week period. Antigen (20 µg) was mixed with an equal volume of 
Freund’s complete adjuvant (Sigma) for the first injection. Subsequent injections were 
conducted using 20 µg of protein mixed with an equal volume of Freund’s incomplete 
adjuvant (Sigma).  
   
The blood collected from rabbit or mouse was allowed to clot at room 
temperature for overnight. The antiserum was collected from the clot by centrifugation at 
1,500 × g for 10 minutes at room temperature. Titers of the antiserum was determined by 
ELISA (Harlow and Lane 1988). Protein A Sepharose CL-4B was used to isolate anti-





2.5 Protein Analytical Techniques 
 
2.5.1 SDS-PAGE Gel Electrophoresis 
 
Proteins were separated by SDS-PAGE gel electrophoresis according to their 
molecular weight. The electrophoresis apparatus used in SDS-PAGE gel electrophoresis 
was the Mini-Protean III Electrophoresis Cell (BioRad). The apparatus was assembled 
according to the instruction manual provided by the manufacturer. For the routine 
analysis of proteins, 12% PAGE gel was used. The polyacrylamide gels (PAGE) for the 
separating gels were prepared as following: 
 
Gel concentration 7% 10% 12% 15% 17.5% 
buffer (1.5M Tris, pH8.8) 1.9 ml 1.9ml 1.9ml 1.9ml 1.9ml 
30% Acrylamide/bis-acrylamide (29:1) 3.5 ml 5 ml 6 ml 7.5 ml 8.75 ml 
10% (w/v) SDS 150 µl 150 µl 150 µl 150 µl 150 µl 
10% (W/V) APS 150 µl 150 µl 150 µl 120 µl 100 µl 
TEMED 9 µl 9 µl 9 µl 8 µl 6 µl 
H2O 9.21ml 7.71ml 6.71ml 5.24ml 4.01ml 
Total volume 15 ml 15 ml 15 ml 15 ml 15 ml 
 
Stacking gel was 2.5% and prepared by mixing 2 ml stacking gel buffer (0.5M 
Tris, pH6.8), 1.3ml 30% acrylamide/bis-acrylamide, 80 µl 10% SDS, 80 µl 10% APS, 8 
µl TEMED and 4.5 ml H2O. 
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Before loading, proteins sample was mixed with 2 × loading buffer (100mM Tris 
pH6.8, 200mM DTT, 4% SDS, 0.2% bromophenol blue, 20% Glycerol) and boiled for 3 
~ 5 minutes to fully denature the protein and reduce disulfide bonds. The gel  was run at a 
constant voltage of 100 V until the bromophenol blue reached the bottom of the gel. After 
SDS-PAGE, the gel was stained in Coomassie staining solution (45% methanol, 10% 
acetic acid and 0.25% coomassie brilliant blue R-250) for 2 ~4 hours and then destained 
with destain solution containing 5% methanol and 7.5% acetic acid. The destained gel 
was washed in water to remove the organic solvents before drying. 
 
2.5.2 Western blot Analysis 
 
For Western blot analysis, proteins separated by SDS-PAGE gel electrophoresis 
were transferred electrophoretically onto a nitrocellular membrane with Mini Trans-Blot 
Cell (Bio-rad). The transfer buffer used in this study was Towbin buffer (3.03g/l Tris, 
14.4 g/l Glycine, 20% V/V Methanol). Transfer was performed either at 75 mA for 2~3 
hours or at 30 mA for overnight at 4°C. After the transfer was completed, the membrane 
was removed from the sandwich and then incubated with 5% non-fat milk in TBST 
buffer (20 mM Tris, 150 mM NaCl, 0.05% V/V Tween-20, pH 7.4) to block the 
remaining protein-binding sites in the membrane. The blocking reaction was carried out 
for 1 hours at room temperature on an orbital shaker. After blocking reaction was 
completed, the membrane was washed at least three times with TBST buffer for ten 
minutes each on a rocking platform. Then, the membrane was incubated with the TBST-
diluted primary antibody (usually use 100ug/ml as final concentration) for 1 hour at room 
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temperature while continuously rocking the sample. To remove the unbound primary 
antibody, the membrane must be washed at least three times as aforementioned. After the 
washing was completed, the membrane was incubated with the TBST-diluted second 
antibody (usually in a 1:5000 dilution). The unbound second antibodies were washed 
away by three extensive TBST washes. The fluorescence produced by the HRP 
(horseradish peroxidase) -conjugated second antibody was detected with the SuperSignal 
West Pico System (Pierce). 
 
2.5.3 In-Gel Digestion, MALDI-TOF and Tandem MS Sequencing 
 
Protein bands were carefully excised from the gel, cut into small pieces, and then 
destained with several washes of 50 mM ammonium bicarbonate in 50% aqueous 
acetonitrile. The gel pieces were dehydrated with 100% acetonitrile and dried in Savant 
Speed-vac. The dried gel pieces were rehydrated with a solution containing 10 mM DTT 
and 100 mM ammonium bicarbonate and incubated at 57°C for 60 min to reduce the 
disulfide bonds. The reduced sulfhydryl group was alkylated by 55 mM iodoacetamide in 
100 mM ammonium bicarbonate at room temperature for 60 minutes. After alkylation, 
the gel pieces were first washed with 100 mM ammonium bicarbonate solution, then 
dehydrated with 100% acetonitrile at least 6 times, and then dried in Savant Speed-vac 
again. Sequencing grade modified trypsin (12.5 mg l
-1 
in 50 mM ammonium bicarbonate, 
pH 8.0) was added to the dried gel pieces and incubated overnight at 37°C. The resulting 
trypsinized peptides were extracted with 20 mM ammonium bicarbonate solution, 5% 
formic acid in 50% aqueous acetonitrile, and 100% acetonitrile, respectively. The 
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extracted peptides were combined, lyophilized, and then resuspended in 0.1% 
trifluoroacetic acid (TFA). An aliquot of the resuspended peptides was spotted onto the 
stainless steel MALDI sample plate and overlaid with equal volume of matrix solution 
(20 g l
-1 
α-cyano-4-hydroxycinnamic acid in 0.1% TFA; 50% aqueous acetonitrile). The 
sample (matrix mixture) was allowed to air dry. An Applied Biosystems Voyager-DE 
STR MALDI mass spectrometer was used to acquire the MALDI-time of flight (TOF) 
spectra. The instrument was operated in the positive reflector delayed extraction mode. 
Peptide mass spectra were searched against theoretically spectra derived from proteins in 
the non-redundant databases of National Center for Biotechnology Information (NCBI) to 
match peptide mass fingerprints. Partial amino acid sequence of a single peptide was 
obtained by quadrupole-time of flight (Q-TOF) hybrid tandem mass (MS/MS) 
spectrometer. For Q-TOF MS/MS analysis, the trypsinized peptide samples were 
concentrated and desalted by the Zip-Tip method. Based on the mass spectra acquired by 
MALDI-TOF, dominant peptides were selected for MS/MS analysis. After peptides were 
selected, the Q-TOF mass spectrometer was automatically switched from MS to MS/MS 
mode and the Q-TOF MS/MS spectra were collected. The amino acid sequences were 
determined by searching the Q-TOF MS/MS spectra against the NCBI non-redundant 
protein databases (Westermeier 2002).  
. 
2.5.4 N-Terminal Sequencing 
 
Purified protein sample (1 ~ 2 mg/ml) was loaded into the ABI Procise 494 
Protein Sequencer for N-terminal sequencing analysis. Principally, in this reaction 
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phenylisothiocyanate (PITC) reacts with the amino acid residue at the amino terminus 
under basic conditions (provided by n-methylpiperidine/methanol/water) to form a 
phenylthiocarbamyl derivative (PTC-protein). Trifluoroacetic acid was then used to 
cleave off the first amino acid as its anilinothialinone derivative (ATZ-amino acid) and 
leave the new amino terminus for the next degradation cycle. The ATZ amino acid is then 
removed by extraction with N-butyl chloride and converted to a phenylthiohydantoin 
derivative (PTH-amino acid) with 25% TFA/water. The PTH-amino acid is transferred to 
a reverse-phase C-18 column for detection at 270 nm. This chromatogram provided 
standard retention times of the amino acids for comparison with each Edman degradation 
cycle chromatogram. The HPLC chromatograms were collected using a computer data 
analysis system. To determine the amino acid present at a particular residue number, the 
chromatogram from the residues of interest was compared with the chromatogram from 
the previous residue by overlaying one on top of the other. From this, the amino acid for 
the particular residue can be determined. This process was repeated sequentially to 
provide the N-terminal sequence of the protein. 
(http://www.protein.iastate.edu/nsequence494.html) 
 
2.5.5 Circular Dichroism (CD) Spectrum 
 
Circular Dichroism (CD) spectroscopy is a type of absorption spectroscopy that 
can provide information on the secondary & tertiary structures of many types of 
biological macromolecules. Circular Dichroism is the difference between the absorption 
of left and right handed circularly-polarised light and is scanned as a function of 
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wavelength. Biological macromolecules, such as proteins, carbohydrates and nucleic 
acids, are composed of many optically active or chiral units that exhibit large CD signals. 
CD spectroscopy has therefore been used extensively in the study of proteins, where 
asymmetric carbon atoms in their amino-acid 'backbone' give rise to a CD spectrum. The 
shape of the spectrum depends on the protein's secondary structure content and allows the 
proportions of helix, beta structure, turns and random coil to be determined. 
 
Purified protein was diluted in phosphate buffer to final concentration of 100 




2.5.6 Dynamic Light Scattering (DLS) 
 
The dynamic light scattering (DLS) is a well established technique for measuring 
particle size over the size range from a few nanometers to a few microns. The technique 
uses the idea that small particles in a suspension move in a random pattern. When a beam 
of light passes through a colloidal dispersion, the particles or droplets scatter some of the 
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light in all directions. When the particles are very small compared with the wavelength of 
the light, the intensity of the scattered light is uniform in all directions; for larger particles 
(above approximately 250 nm diameter), the intensity is angle dependent. If the light is 
coherent and monochromatic, as from a laser for example, it is possible to observe time-
dependent fluctuations in the scattered intensity using a suitable detector such as a 
photomultiplier capable of operating in photon counting mode. 
(http://www.brookhaven.co.uk/dynamic-light-scattering.html). Observation of larger 
particles compared to smaller particles will show that the larger particles tumble more 
slowly than the smaller ones if the temperature is the same. According to Einstein's 
developments in his Kinetic Molecular Theory (applied to heat), molecules that are much 
smaller than the particles can impart a change to the direction of the particle and its 
velocity. Thus water molecules (0.00033 microns) can move polystyrene particles as 
large as a couple of microns. The combination of these effects is observed as vibrations 
and an overall movement of the particle. Concentrated and purified protein prior to 
crystallization was tested for homogeneity using the Dynamic Light Scattering (DynaPro, 
Protein Solutions). A few minutes are required for the sample and cell to equilibrate with 
the actively controlled temperature environment. The cuvette must be washed with sterile 
water until the counts are below 10. Then 50 µl concentrated sample was loaded into the 








Crystallization screens were performed using the hanging-drop method with 
Hampton 24-well plastic plates at 20 °C. The initial screens were carried out using 
Hampton crystallization screen kits (crystal screen 1&2, index). A drop composed of a 
mixture of 1 µl protein solution and 1µl reservoir solution is placed in vapor equilibration 
with a liquid reservoir of regent. The initial conditions were optimized to get diffraction-
quality crystals. The crystals were soaked into the cryoprotectant buffer before flash-
frozen in liquid nitrogen for data collection. 
 
2.7 Data Collection 
 
X-ray diffraction data were collected at 100°K using synchrotron radiation. A 
three wavelength experimental data set for the rVP28 crystals was collected at beamline 
X29, NSLS, USA while that of rVP26 crystals was collected at beamline X26C, NSLS, 
USA. Data for rVP26 and rVP28 were processed and scaled using the HKL suite 
(Otwinowski and Minor 1997).  
 
2.8 Structure Determination 
 
The structure of rVP28 and rVP26 were determined using the MAD method. The 
position of the seleno-methionine were determined and phases computed with SOLVE 
(Terwilliger and Berendzen 1999). Density modification was effected by using 
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RESOLVE (Terwilliger 2000). The resulting electron density map was not good enough 
and the model was built manually by using the program O (Jones et al. 1991). The initial 
model was refined by rigid body, individual B-factor and energy minimization refinement 
using CNS (Brunger et al. 1998). For rVP28, the restrained non-crystallographic 
symmetry (NCS) was applied to increase the observation to parameter ratio throughout 
the CNS refinement. Also, the test set (Rfree) was introduced into the refinement to 
monitor and validate the model refinement. At each round of refinement, the geometry of 
the structure was checked with PROCHECK using the Ramachandran plot (Laskowski et 
al. 1993). Water molecules are added in the final stage of refinement. Structural 














3 Characterization of WSSV Envelope Proteins 
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3.1 Characterization of Envelope Protein VP300 
 
3.1.1 Identification of VP300 by Mass Spectrometry 
 
Purified WSSV virions were separated by SDS-PAGE (Figure 3.1). More than 30 
bands were visualized using Coomassie brilliant blue R-250 staining. Many major bands 
have been identified previously (such as VP19, VP24, VP26 and VP28 as envelope 
proteins and VP15 as nucleocapsid) however many minor bands are still undefined. The 
band highlighted by red arrow was excised and digested by trypsin and analyzed by 
MALDI-TOF mass spectrometry. Search the WSSV ORF database with the masses of a 
list of trypsin-treated peptides has identified a protein as the product of the vp300 gene. 
The ORF is located between nucleotide position 132994-133893 on the genome (Yang et 
al. 2001). This 900 bp ORF presumably encoded a 300 aa protein (hence termed the 
vp300 gene, GenBank accession number AF403003, and the resulting protein termed 
VP300). One more interesting finding from the mass spectrometry result is that VP292 is 
also identified by MALDI and Q-TOF from the same band. The mass spectrometry result 
is consistent with previous proteomic research (Tsai et al. 2004; Zhang et al. 2004). It 
suggests that VP300 might be a WSSV virion-associated protein.  
 
3.1.2 Expression and Purification of VP300 
 
The VP300 gene was amplified by PCR from the WSSV genome and inserted 













Figure 3.1 1D SDS-PAGE of the WSSV proteins 
 
Viral proteins were purified and separated via one-dimensional SDS-PAGE. Left lane is 
the protein marker and the right lane is WSSV proteins. Four major structural proteins 
(VP19, VP24, VP26 and VP28) are indicated by black arrow. The band highlighted by 
red arrow was excised and digested by trypsin and then analyzed by MALDI-TOF mass 
spectrometry. The search of WSSV ORF database with a list of trypsin-treated peptide 

















expressed in the BL21 (DE3) cell and purified by Ni-NTA under denaturing condition. 
Figure 3.2 shows that SDS-PAGE gel of the purified VP300 protein. The purified protein 
was injected into mouse to raise the mouse anti-(His)6-VP300 antibody as mentioned in 
Chapter Two. 
 
3.1.3 Localization Study of VP300 
 
3.1.3.1 Western Analysis of VP300 
 
To test specificity of the anti-VP300 antibody, western blot analysis was 
performed. From Figure 3.3A, the purified mouse anti-(His)6-VP300 IgGs was used and 
it can detect the VP300 protein among a mixture of all viral proteins as well as the 
positive control of purified (His)6-VP300 protein. As a negative control, the antibody did 
not react with purified VP281, another envelope protein of WSSV. It showed that the 
purified mouse anti-(His)6-VP300 IgGs reacted specifically with VP300. Also it proved 
that VP300 was of the WSSV origin rather than a contaminating protein linked 
superficially to the WSSV virion. To further identify the location of VP300 in the virion, 
the virus sample was fractionated into envelope and nucleocapsid fractions by the 
treatment with 2% Triton X-100. As in Figure 3.3B, the western blot result shows that 
VP300 was clearly detected in the WSSV whole virion and the purified viral envelope 
fraction. However, the anti-VP300 antibodies did not react with the proteins of WSSV 










Figure 3.2 Expression of the purified (His)6-VP300 protein 
 
Shown are Coomassie Brilliant Blue –stained 12% SDS-PAGE gels.  
Lane 1, protein marker;  
Lane 2, recombinant pET-32(a) plasmid containing vp300 gene, non-induced;  
Lane 3, recombinant pET-32(a) plasmid containing vp300 gene, induced;  




















Figure 3.3 Western blot analysis of WSSV with anti-VP300 IgG 
 
Figure 3.3A is Coomassie Brilliant Blue-stained SDS-PAGE gels and the corresponding 
western blot analysis with anti-VP300 IgG.  
Lane 1, purified (His)6-VP300 protein as positive control;  
Lane 2, purified VP281 protein as negative control;  
Lane 3, protein marker;  
Lane 4, WSSV virion.  
 
Figure 3.3B is the western blot analysis of the different fractions of WSSV with anti-
VP300 IgG.  
Lane 1, WSSV whole virion;  
Lane 2, WSSV viral envelope;  
Lane 3, WSSV nucleocapsid. 
VP300
Western blot with anti-VP300 antibody  Coomassie Brilliant Blue-stained gel 
 1 2 3 4  1          2          3          4 
A 
B 
1                                2         3 
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3.1.3.2 TEM Immunogold-Labeling Analysis 
 
TEM immunogold-labeling method was further used to confirm the location of 
VP300. The results shown in Figure 3.4 demonstrated that high-density gold particles 
were located specifically at the viral envelope, while no apparent signals could be 
observed in the nucleocapsid. The mouse anti-(His)6 antibody was also used as control to 
replace the anti-(His)6-VP300 IgGs but no gold labeling signals were observed in the 
viral envelope. From the Western blotting assay and TEM observations, it is concluded 
that VP300 is a WSSV envelope protein. 
 
3.1.4 Neutralization Assay of VP300 
 
Virus envelope proteins play important roles in viral infection, such as recognition 
and attachment to receptors on the surface of host cell. So being an envelope protein, is 
VP300 involved in viral entry during infection? In an attempt to identify the envelope 
protein’s involvement in WSSV infection on shrimp, the neutralization assay of infection 
by WSSV virion with antibodies against VP300 was performed. First, the suitable dosage 
of WSSV for shrimp infection was determined by performing an in vivo virus titration. 
As expected, the mortality varied among groups of shrimp injected with different amount 
of viruses. Delay in shrimp mortality was observed with the serial dilution of virus. When 
the WSSV virion was diluted in PBS buffer with a ratio of 1:106, a mortality of 100% 
was observed in a period of 11 days (Figure 3.5B). Based on the in vivo virus titration, 







Figure 3.4 Localization of WSSV VP300 proteins by immunoelectron microscopy 
 
A, gold particles localize in virus envelope (arrow indicated);  
B, No gold particles was found in the nucleocapsid.  
The primary antibody is the purified mouse anti-(His)6-VP300 IgG, and the second 









































Figure 3.5 Neutralization Analysis of WSSV infections 
 
A, Neutralization of WSSV infection in crayfish by antibody against VP300.  
B, Dosage of WSSV for shrimp infection.  





because it is expected to give the optimal response to the neutralization in terms of 
mortality. After we selected the suitable dosage of WSSV, we performed the 
neutralization assay by adding specific antibodies. The antibodies against VP300 and 
WSSV virion, as well as the anti-GST antibodies as control, were used in the in vivo 
neutralization assays. After incubation of WSSV with each antibody, the mixtures were 
injected into shrimp. The results are shown in Figure 3.5A. It showed that the shrimp 
mortalities were very low, almost zero for the negative control (0.9% NaCl), whereas the 
shrimp from the positive control (WSSV only) displayed 100% mortality in 15 days post-
infection. However, when the mixture of WSSV and anti-VP300 IgGs was injected, the 
shrimp mortality fell significantly to almost zero, indicating that the infection of WSSV 




Proteomic study by mass spectrometry had identified the existence of VP300 
protein in the WSSV virion. From the SDS gel, the observed molecular mass of VP300 is 
around 38 KDa, which is greater than the theoretical molecular mass (34.4 KDa) of the 
vp300 gene product. This difference indicates that some posttranslational modifications 
might have occurred. Computer assisted analysis revealed that there are three possible 
phoshporylation sites and one potential N-linked glycosylation site in VP300. 
Furthermore, VP292, an envelope protein that previously confirmed by Huang et al 
(2002), was also detected by mass spectrometry from the same SDS PAGE band. When 
we compared the protein sequence of VP300 and VP292, there is no significant 
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homology. Since the functional characterization of VP292 is still in progress, we cannot 
confirm any functional relationships between these two proteins.   
 
Besides the mass spectrometry results, the observations from Western blot and 
immuno-gold labeling TEM further confirmed that VP300 is a WSSV envelope protein 
but not a nucleocapsid protein. Similar to many known membrane proteins, VP300 has a 
transmembrane region predicted by sequence analysis using the DAS server (Stockholm 
University). It suggests that this hydrophobic region was responsible for insertion into 
membrane lipid bilayer and VP300 may be a membrane anchor protein. 
 
To date, several envelope proteins have been identified (VP19, VP31, VP24, 
VP26, VP28, VP124, VP281, VP292, VP466). Previous neutralization study of six 
WSSV envelope proteins indicates that some of the envelope proteins had function on 
viral infection while some do not. In this study, neutralization assay showed that the anti-
VP300 IgGs functions to delay or neutralize the infection of shrimp by WSSV. The 
antibody against VP300 could bind to envelope spikes on the virion and prevent the 
attachment of the virus to the cell surface or uncoating of the virus (Burton et al. 2000; 
Wu et al. 2005). VP300 might be a key protein in viral invasion and could be a good 
candidate for screening of receptors on the cell surface. Further study on VP300 would 
help to understand the mechanism of the virus infection. Up until now, no efficient 
method has been found to prevent the infection of shrimp by WSSV. Antibody against 
VP300 could be used directly as a passive immune strategy to control the WSSV 
infection. 
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3.2 Localization Study of VP26 in WSSV virion 
 
3.2.1 Immunogold labeling of VP26 in WSSV particles  
       (This part of experiments was done by Dr. Jinlu Wu) 
 
Compared with the confirmed envelope protein of VP28, the location of VP26 in 
the virion is still unclear. VP26 was first reported as a nucleocapsid protein (van Hulten 
et al. 2001b) and later reported as an envelope protein (Zhang et al. 2002b). However, the 
most recent publications claimed that VP26 is a linker (Xie and Yang 2005) or a 
tegument protein (Tsai et al. 2006). Clarification of the location of VP26 should improve 
our understanding on function of the protein.  
   
To study the location of VP26 in the virion, the virus was treated with Tween 20 
to get partial and complete separation of viral envelope from the nucleocapsid so that we 
can distinguish the location of gold particles. Figure3.6 shows that the detergent 
treatment separated the envelope from the nucleocapsid. Interestingly, some completely 
separated envelope formed vesicles of different sizes and shapes. The treatment also 
resulted in visible surface projections and spike-like structures, which were not observed 
on the envelope of an intact virion. Figure 3.6A-3.6D show immunogold-labeled VP26, 
and Figure 3.6E show immunogold-labeled VP28. All gold particles were found to bind 
at the outer surface of the envelope, while none bind to the inner surface of envelope, 
nucleocapsid or the space between them. Some gold particles were clearly localized on 
the spike-like structures when using anti-VP26 for immunogold labeling (insert in Figure 




















VP26 and VP28 are both envelope proteins. Purified WSSV virion was treated with 0.1% 
Tween 20 and then was immunogold labeled with VP26 and VP28 antibodies. A-D show 
VP26 antibody specially binds to outer surface and the gold particles are localized on the 
outer surface of virions (A-i, C-i), semi-separated envelope (B-i) and fully separated 
envelope (envelope vacuoles, A-ii, C-ii, D-i). E shows immunogold labeled VP28 is also 
localized on the outer surface of envelope. Surface projects (solid arrows) and spike-like 
(empty arrow) structures clearly appeared on some of the envelope (C-i and E-i) and 
vesicles (D-i), respectively. The insert in D shows a large view of spike-like structures. F 
shows a very low binding background when a pre-immune rabbit antibody or gold-
conjugated secondary antibody was used. The F also shows a possible process of vesicle 
formation (bar=100 nm). The EM experiment was preformed by Dr. Jinlu Wu. 
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and a possible mechanism for the formation of vesicles. On the other hand, if the virion 
was over treated with Tween 20, VP26 can only be scarcely labeled. We also tried to treat 
the virion with 0.1% Triton X-100, but such treatment always resulted in complete loss of 





Due to the dispute over the location of VP26, we have carried out an examination 
on VP26 by immunoelectron microscopy in this study. In this study we chose to use 
Triton X-100 and Tween 20 to treat the virion to expose antibody binding sites and to 
separate the envelope from the nucleocapsid. Our result showed that 0.1% Tween 20 
could effectively separate the envelope from the nucleocapsid, but the treatment with 
0.1% Triton X-100 was too harsh and resulted in complete loss of envelope during 
subsequent steps of immunogold labeling. More interestingly, surface projections and 
spike-like structures could be observed in the outer surface of the envelope after 
treatment with Tween 20. It suggests that the envelope structure became loosely packed, 
thus more antibody binding sites for both VP26 and VP28 were exposed resulting in 
higher labeling efficiency. Even though, no gold particles were observed in the space 
between the inner surfaces of envelope or the nucleocapsid, all the gold particles were 
localized on the outer surface of the semi or fully separated envelope. Taken together, we 
proposed that VP26 itself is an envelope protein and is anchored at the viral lipid bilayer 
by its N-terminal transmembrane region.  
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3.3 Candidates for Structure Analysis 
 
3.3.1 Solubility Test of Major Envelope Proteins 
 
Although many structural genomic programs have used different criteria or 
priorities for the selection of target proteins (Brenner 2001), the common theme is to 
restrict the selection to candidates to proteins of unknown structure, expected interest and 
accessibility (yields, solubility and ease of labeling etc). In the present proposal, we have 
focused on the envelope proteins what are important for viral infection, assembly and 
morphogenesis. These candidates were expressed in a bacterial system. The yield and 
solubility of these proteins were examined and protocols will be developed for protein 
purifications and characterization. To express and purify all these envelope proteins, the 
encoding DNA fragment was cloned into different kinds of vectors, including pET15b, 
pET32(a), pGEX-4T-2 and pGEX-6P-1 and then transformed into the BL21 (DE3) cell 
for expression as mentioned in Chapter Two. All envelope proteins, except for VP281, 
are predicted to contain a transmembrane domain. So the first step is to check the 
solubility of these full length proteins. Initial trials were performed by expression using 
0.1 mM IPTG at 30 °C for 4 hours. The expression condition was optimized by changing 
the final concentration of IPTG and culture temperature. As shown in Figure 3.7, when 
expressed as GST fusion proteins, VP281 and VP466 were partially soluble when the 
cells with the recombinant plasmid were cultured at the optimal condition. But for VP19, 
VP24, VP28 and VP68, they were all expressed as insoluble proteins. VP281 and VP466 
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Figure 3.7 Solubility study on the envelope proteins of WSSV 
 
Six envelope proteins are tested for their solubility in their optimal conditions. Lane 1, 
supernatant; Lane 2, pellet. VP281 and VP466 are partially expressed in soluble fraction 
while VP28, VP26, VP19 and VP68 are expressed in the inclusion body.  
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3.3.2 Purification of VP281 Protein and Crystallization Trials 
 
The solubility test showed that VP281 and VP466 were expressed as soluble 
proteins in a bacterial system. Thus we performed the large scale expression and 
purification of these two proteins. The vp281 gene was cloned into pGEX-6P-1 using the 
restriction enzyme sites, BamHI and EcoRI. The VP281-GST fusion protein was first 
purified using glutathione sepharose and then the GST tag was removed by the cleavage 
using ProScission protease as mentioned in Chapter Two. The expressed protein is 286 aa 
in size with predicted MW of 31970.80 Da and pI of 4.47. There are 4 cysteine residues 
in the VP281 sequence indicating that disulfide bonds might form inside VP281 to 
stabilize its fold or/and to form linkage between two VP281 molecules.  
 
The SDS-PAGE gel of purified VP281 is shown in Figure 3.8. Further 
purification of VP281 was performed by ion exchange, hydrophobic interaction 
chromatography (HIC) and size exclusion chromatography. MALDI-TOF MS and Q-
TOF MS as well as N-terminal sequencing were carried out to confirm the identity of the 
purified protein. MALDI-TOF MS result showed that the amino acid sequence coverage 
is about 42% (120 of 281). And the Q-TOF MS result showed that the MW of VP281 is 
31973.80 Da, almost the same as the theoretical MW of 31970.80 Da. The N-terminal 
sequence of 12 amino acids also confirmed identity of the purified VP281 protein. A CD 
spectrum was also taken to study the secondary structure of this protein and from the 




















Figure 3.8 Expression of the purified VP281 protein 
 
Shown is Coomassie Brilliant Blue –stained 12% SDS-PAGE gel.  
Lane 1, protein marker;  
Lane 2, pGEX-6P-1 (vector only as control)-pLysS, non-induced;  
Lane 3, pGEX-6P-1-pLysS, induced;  
Lane 4, recombinant pGEX-6P-1 plasmid containing vp281 gene, non-induced;  
Lane 5, recombinant pGEX-6P-1 plasmid containing vp281 gene, induced;  
Lane 6, purified GST-VP281 protein;  
Lane 7, GST-VP281 fusion protein cleavage with ProScission™ protease;  
Lane 8, purified VP281 protein. 
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Homogeneity of the purified protein is the key to grow a well-diffracting crystal. 
Single band purity on native PAGE is neither a sufficient nor a necessary prerequisite to 
obtaining crystals but has always been regarded as a good starting point for crystal 
growth. The native gel and SDS-gel together will give some hints about the extent of 
protein aggregation. The purified VP281 protein was concentrated to 10 mg/ml and ran in 
native gel. The gel filtration profile showed that the protein was eluted as a dimeric but 
when running in the native gel we could clearly see several bands, indicating that there 
was significant aggregation happened in VP281 protein. The most frequent cause of non-
specific aggregation is suboptimal protein solvent conditions. We have tried to change 
the buffer condition, such as the concentrations of NaCl, glycerol and the reducing agent, 
but to no avoid. However, there was no apparent difference of all in the variations in the 
native gel. It is impossible to obtain any diffraction-quality crystals from this poor quality 
protein. Further purification steps or truncation treatments are required for this protein for 
crystallization. 
 
3.3.3 Purification of VP466 Protein and Crystallization Trials 
 
The vp466 gene was cloned into pGEX-4T-1 between the restriction enzyme sites, 
BamHI and XhoI. VP466 was first expressed as a GST fusion protein using Glutathione 
sepharose 4B beads and then the GST tag was removed by thrombin protease cleavage. 
The SDS-PAGE gel of purified VP466 is shown in Figure 3.9. The corresponding bands 
were excised from the gel, digested by trypsin and then portion of tryptic peptide 



















Figure 3.9 Expression of the purified VP466 protein 
 
Shown is Coomassie Brilliant Blue –stained 12% SDS-PAGE gel.  
Lane 1, protein marker; 
Lane 2, pGEX-4T-1 (vector only as control)-pLysS, non-induced; 
Lane 3, pGEX-4T-1-pLysS, induced; 
Lane 4, recombinant pGEX-4T-1 plasmid containing vp466 gene, non-induced; 
Lane 5, recombinant pGEX-4T-1 plasmid containing vp466 gene, induced; 
Lane 6, purified GST-VP466 protein; 
Lane 7, GST-VP466 fusion protein cleavage with thrombin protease; 




42% of the whole sequence (198 of 466). And the Q-TOF MS result showed that the MW 
of VP466 was 52053.20 Da, slightly larger than the predicted M.W. of 52052.30 Da, but 
the difference was within the allowable error range. Furthermore, the N-terminal 
sequence of 14 amino acids also confirmed the identity of the purified VP466 protein. A 
CD spectrum showed that VP466 has a typical α-helical secondary structure.  
 
  The single band of purified VP466 protein in native gel indicated that the protein 
was homogenous. However we were unable to get any crystals from the crystallization 
screening. More crystallization trials on purified VP466 will be performed under different 
conditions. Different crystal growth techniques like sitting drop vapor diffusion or under 














4 Crystal Study of Two Major Envelope Proteins 
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4.1 X-ray Structure of Major Envelope Protein VP28 
 
4.1.1 Property of rVP28 Protein 
 
VP28 and VP26 are two most abundant envelope proteins that consist 60% of the 
envelope. Previous experiments have shown VP28 play important role in WSSV 
infection and VP26 was able to interact with actin. As their importance and abundance in 
viral envelope, we selected these two proteins for the structure determination. As we 
mentioned before that the expression and purification trials on full-length VP28 and 
VP26 resulted in a very low level of expression and the production of an insoluble 
protein. Extensive detergent screen to solubilize and crystallize the protein was 
unsuccessful. Sequence analysis using DAS server (Stockholm University) indicated the 
presence of a transmembrane region at the N-terminal region of VP28 and VP26 (Figure 
4.1). We hypothesized that removal of the transmembrane region would increase the 
solubility and the yield of crystals. Thus we designed a construct encoding the major part 
(Asn31-Glu204) of VP28 without the N-terminal transmembrane domain (Met01-His30).  
 
Theoretical pI and MW of rVP28, the truncated protein, is 4.63 and 19258.47 Da 
respectively. The SDS-PAGE electrophoresis is shown in Figure 4.2. The homogeneity of 
purified rVP28 at different concentration was tested by native gel and dynamic light 
scattering experiment respectively. The gel filtration profile as well as the dynamic light 
scattering data showed that rVP28 is a monomer in solution. rVP28 at a concentration of 






Figure 4.1 DAS transmembrane prediction result for full length VP28 and VP26 
 
These curves are obtained by pairwise comparison of the proteins in the test set in 
"each against the rest" fashion. There are two cutoffs indicated on the plots: a "strict" one 
at 2.2 DAS score, and a "loose" one at 1.7. The hit at 2.2 is informative in terms of the 
number of matching segments, while a hit at 1.7 gives the actual location of the 
























Figure 4.2 Expression of the rVP28 protein in E.coli BL21 DE3 star 
 
Shown is Coomassie Brilliant Blue –stained 12% SDS-PAGE gel 
Lane 1, protein marker;  
Lane 2, recombinant pGEX-6P-1 plasmid containing vp28 gene, non-induced;  
Lane 3, recombinant pGEX-6P-1 plasmid containing vp28 gene, induced;  
Lane 4, purified GST-rVP28 protein;  
Lane 5, GST-rVP28 fusion protein cleavage with ProScission™ protease;  




4.1.2 Preparation of SeMet rVP28 Protein 
 
As VP28 lacks homology with any other known structure of viral proteins, the 
MAD method was used to solve the structure of rVP28. The seleno-methionine rVP28 
was expressed in defined LeMaster medium using the methionine auxotrophic strain 
(DL41). The purification procedure was the same as that for the native protein. The 
SeMet rVP28 was purified by Superdex-75 gel filtration chromatography using a gel 
filtration buffer containing 20 mM Tris-Cl (pH 7.4), 150 mM NaCl, 10 mM DTT and 5% 
Glycerol. The purified SeMet rVP28 was concentrated to around 10 mg/ml for 
crystallization. To confirm the substitution status, the MW of seleno-methionine rVP28 
and the native rVP28 were determined by MALDI TOF MS. The MW difference of 
native and seleno-methionine rVP28 was around 271 Dalton, while the MW difference of 
selenium and sulfur is 46.895 Dalton, indicating that all of the six methionine residues of 
rVP28 were fully substituted by seleno-methionine. 
 
 
4.1.3 Crystallization of rVP28 
 
The initial crystals were obtained using under oil method. The condition was        
later optimized using the hanging drop method to obtain diffraction-quality crystals. 
Glycerol was used as the cryoprotectant for flash-frozen in liquid nitrogen. The details of 





Table 4.1 Summary of Crystallization Conditions and Cryoprotectants 









0.2 M Ca acetate 





Optimized Crystallization condition 
 
25% PEG8K 
0.2 M Ca acetate 
0.1 M Na HEPES (pH 7.5) 







0.2 M Ca acetate 





4.1.4 Structure Determination of rVP28 
 
The structure of the recombinant SeMet VP28 was solved using the MAD method. 
Three data sets in different wavelength were collected from the synchrotron beam line 
X29 at the Brookhaven National Laboratories. Data were processed and scaled using the 
HKL suite. BNP was used to locate the Se sites for VP28.  
 
The phases were further developed using RESOLVE which improved the overall 
FOM (figure of merit) to 0.75. The initial models were built automatically by RESOLVE 
containing ~50% of the total residues. The rest of the model was manually built using 
program O and refined using the program CNS interspersed with several rounds of 
manual refitting. All the measured reflections were used in the refinement. The 
asymmetric unit of VP28 consists of twelve molecules. Throughout the refinement the 
Non Crystallographic Symmetry (NCS) restraints were used for VP28. The final R-
factors for VP28 is 0.24 (Rfree=0.28) at 2.0Å resolutions. The model was refined with 
good stereochemical parameters. Statistics of the Ramachandran plot from an analysis by 
PROCHECK gave an overall 89.7% of non-glycine residues in the most favored region 
and only Asp166 in the generously allowed regions. This residue belongs to a less well-
ordered segment connecting two β strands. The details of data collection and refinement 









Cell parameters and angles   a=105.33, b=106.71, c=200.37, α=β=γ=90° 
Space group     P212121 
Data collection                 Peak          Inflection           Remote 
Resolution range (Å)              50-2.0          50-2.1  50-2.1  
Wavelength (Å)              0.9796          0.9799  0.9600 
Observed Reflections>1             1818612         1608124     774774 
Unique Reflections   152547         132247  131772 
Overall (I/σI)    15.3          15.9  15.5 
Redundancya    11.9(9.7)         12.2(11.2) 5.9(5.4) 
Completenessa (%)   100(99.9)         100(100)         99.7(99.5)  
Rsyma,b (%)    0.08(0.209)         0.072(0.179)  0.073(0.181) 
Refinement 
Resolution range (Å)   45.0-2.0 
Number of Reflections  294116 
R factorc (%)    24.82  
Rfreed (%)    28.12 
RMSD bond lengths (Å)  0.008 
RMSD bond angles ( °)  1.24 
Average B-factors (Å2)  60.00 
Water molecules   1422 
Ramachandran Plot 
Most favored region (%)  89.7    
Additional allowed regions (%) 9.7    
Generously allowed regions (%) 0.6 
Disallowed regions (%)   0.0 
 
 
a Last shell values givn in parentheses. 
b.Rsym = |Ii -<I>|/|Ii| where Ii is the intensity of the ith measurement, and <I> is  the mean intensity for that reflection. 
b Rwork = | Fobs - Fcalc|/|Fobs| where Fcalc and Fobs are the calculated and observed  structure factor amplitudes, respectively. 
c Rfree is calculated using the same equation as that for R work but 3% of reflections where chosen randomly and omitted from the refinement. 
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4.1.5  Overall Structure of rVP28 
 
The full-length rVP28 exhibits single β-barrel architecture and an α-helix is 
protruding from the β-barrel. The N-terminal extended (protruding) α-helix is 15 residues 
(Thr32-Asn47) of approximately 23 Å in length from the surface of the β-barrel. A total 
of nine β-strands (β1↓β2↑β3↓β4↓ß5↑β6↓β7↑β8↓β9↑), mostly anti-parallel, form the 
barrel. The N-terminal protruding α-helix is linked by 2 residues to the core β-barrel. The 
overall dimension of the β-barrel is approximately 35 Å (height) x 15 Å (diameter) 
(Figure 4.3).  
 
The pore of the β-barrel is highly hydrophobic in nature with 25 hydrophobic side 
chains lining the inner surface, contributed by side chains from seven Phe, eight Ile, one 
Leu, four Met and five Val residues. Taken together the size and the hydrophobic nature 
of the pore, the latter may help to recognize small, specific, hydrophobic ligands/ions 
which could potentially establish hydrophobic or van der Waals interactions with the side 















Figure 4.3 Ribbon diagram of rVP28 monomer.  
 
The N and C termini are labled. Figure was prepared using the programs MOLSCRIPT 






4.1.6 Oligomerization of rVP28 
 
In the crystal, an asymmetric unit consists of twelve copies of rVP28 molecules, 
each with 170 residues from Thr32-Thr201 assembled into four trimers (Figure 4.4). 
However, Gel filtration, SDS-PAGE and dynamic light scattering results showed that 
rVP28 is a monomer in solution. Purified WSSV was treated with RIPA buffer and 
analyzed by non-reducing SDS-PAGE and Western blotting. The bands detected by anti-
VP28 were excised from the corresponding gel and analyzed by MALDI TOF TOF MS. 
There were three bands with different M.W. that matched to masses of a list of trypsin-
treated peptide of VP28. The bands correspond to a trimer (~75KD), dimer (~50 KD) and 
monomer (~25KD, the most abundant species) (shown in Figure 4.5). This suggests that 
VP28 naturally forms trimers in the viral envelope but the trimer species may be very 
fragile during virus purification and lysis treatment, hence it becomes a monomer in 
solution. However, during crystal formation the monomers tend to associate as trimers, 
the most natural oligomerization state of VP28. 
 
In the crystal of rVP28, a channel is formed by the N-terminal α-helix and the 
wall of the β-barrel from each monomer of the trimeric rVP28. The length and weight of 
the channel are approximately 58 X 12 Å. No salt bridges are apparent between any of 
these residues. There are 10 hydrogen bonding contacts (<3.2 Å) and several hydrophobic 
interactions between each monomers of the trimeric rVP28 to keep the integrity of the 
channel. The surface area of a monomer is around 9024 Å2, whereas around 1170 Å2 








Figure 4.4 Ribbon diagram of rVP28 trimer.  
 
A) One trimer of the asymmetric unit. Each monomer of the trimer is shown in different 
color. B) Top view of the trimer. Figures were prepared using the programs 

















Figure 4.5 Western blot analysis of WSSV by anti-VP28 
 
The bands that were detected by anti-VP28 IgGs were excised for MALDI TOF TOF MS. 




4.2 X-ray Structure of Major Envelope Protein VP26 
 
 
4.2.1 Purification of rVP26 and SeMet rVP26 protein 
 
The expression and purification trials on full-length VP26 had resulted in a very 
low expression and the production of an insoluble protein as we have mentioned before. 
We hypothesize that the low solubility was due to the N-terminal strong hydrophobic 
region which was predicted as a transmembrane region by sequence analysis. The 
transmembrane truncated form of VP26 (Asn34-Lys204) were constructed, with the 
theoretical pI and M.W. of 9.57 and 19038.8 Da respectively. The analysis of the 
expressed protein by SDS-PAGE is shown in Figure 4.6.  
 
Similar to the native protein, SeMet substituted rVP26 was purified by Superdex-
75 gel filtration chromatography using a gel filtration buffer containing 20 mM Tris-Cl 
(pH 7.4), 200 mM NaCl, 10 mM DT and 5% Glycerol. It is a monomer in solution as 
confirmed by the gel filtration profile and the native gel. MALDI TOF mass spectrometry 
was used for the measurement of the molecular weight of purified SeMet rVP26 as well 
as native rVP26, to make sure that all of the nine methionine residues of rVP26 were 
fully substituted by seleno-methionine. The purified SeMet rVP26 protein was 
concentrated. The DLS result showed that the purified rVP26 protein was homogenous 
up to a concentration of 10 mg/ml. However aggregation will start to appear in solutions 
with higher concentration. Thus a sample of concentration of 10 mg/ml was used later for 





















Figure 4.6 Expression of the rVP26 protein in E.coli BL21 DE3 star 
 
Shown is Coomassie Brilliant Blue –stained 12% SDS-PAGE gel 
Lane 1, protein marker;  
Lane 2, recombinant pGEX-6P-1 plasmid containing vp26 gene, non-induced;  
Lane 3, recombinant pGEX-6P-1 plasmid containing vp26 gene, induced;  
Lane 4, purified GST-rVP26 protein;  
Lane 5, GST-rVP26 fusion protein cleavage with ProScission™ protease;  





4.2.2 Crystallization, Data Collection and Structure Determination of rVP26 
 
Crystals of rVP26 were grown using the hanging drop vapor diffusion method at 
room temperature. Extensive additives screening was performed to optimize the 
crystallization condition to obtain best diffraction-quality crystals. Glycerol was used as 
the cryoprotectant for flash-frozen the crystals in liquid nitrogen. The details of the 
crystallization conditions and cryoprotectants are listed in Table 4.3. 
 
The structure of the recombinant SeMet rVP26 protein was solved using a MAD 
data set collected from the synchrotron beam line X26 at the Brookhaven National 
Laboratories. Data were processed and scaled using the HKL suite. SOLVE was used to 
locate the Se sited and the phases were further developed using RESOLVE which 
improved the overall FOM (figure of merit) to 0.67. The initial models were built 
automatically by RESOLVE containing ~50% of the total residues. The rest of the model 
was manually built using program O and refined with all the measured reflections using 
the program CNS interspersed with several rounds of manual refitting. The structure was 
refined at 2.1 Å resolution, to a final R-factor of 0.21 (Rfree=0.27). The model has been 
refined with good stereochemical parameters. Statistics for the Ramachandran plot from 
an analysis using PROCHECK (Laskowski et al., 1993) gave an overall 85.3% of non-
glycine residues in the most favored region, with only Ala 58 in the generously allowed 
regions. This residue belongs to a poorly ordered peptide segment connecting two β 
strands. No residue was observed in the disallowed region. The details of data collection 
and refinement are listed in Table 4.4. 
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Table 4.3 Summary of Crystallization Conditions and Cryoprotectants 





Initial crystallization condition 
 
 
0.1 M citric acid (pH 3.5) 





Optimized Crystallization condition 
 
0.1 M citric acid (pH 3.5) 
3.0 M sodium chloride 






0.1 M citric acid (pH 3.5) 










Cell parameters and angels   a=b=73.915, c=199.313; α=β =90°, γ=120° 
Space group        R32 
Data collection   Peak     Inflection             Remote 
Resolution range (Å)   50-2.2       50-2.6  50-2.7 
Wavelength (Å)   0.9782       0.9787  0.9600 
Observed Reflections >1  187787      188815  120101 
Unique Reflections   10798       10841  11519  
Overall (I/σI)    23       19.1  12.3 
Redundancya    17.4(13.9)      17.4(13.5)         10.4(10.1) 
Completenessa (%)   99.9(99.4)      99.7(97.4)         99.8(98.8)  
Rsyma,b (%)    0.090(0.327)      0.088(0.382)  0.082(0.259) 
Refinement 
Resolution range (Å)   45.0-2.2 
Number of Reflections  19998 
R factorc (%)    21.68 
Rfreed (%)    27.85 
RMSD bond lengths (Å)  0.007 
RMSD bond angles ( °)  1.22 
Average B-factors (Å2)  73.74 
Water molecules   153 
Ramachandran Plot 
Most favored region (%)  85.3  
Additional allowed regions (%) 14.0  
Generously allowed regions (%) 0.7 
Disallowed regions (%)  0.0 
 a Last shell values givn in parentheses. 
b.Rsym = |Ii -<I>|/|Ii| where Ii is the intensity of the ith measurement, and <I> is  the mean intensity for that reflection. 
b Rwork = | Fobs - Fcalc|/|Fobs| where Fcalc and Fobs are the calculated and observed  structure factor amplitudes, respectively. 
c Rfree is calculated using the same equation as that for R work but 3% of reflections where chosen randomly and omitted from the refinement. 
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4.2.3 Overall Structure of rVP26 
 
Figure 4.7 shows the crystal structure of rVP26. The asymmetric unit contains one 
VP26 molecule comprising 161 residues from Ser41 to Ile201 and a total of 153 water 
molecules. Residues 34-40 and 202-204 from part of the N-terminal/C-terminal region 
and had no interpretable density and were not modeled. The full-length rVP26 consists of 
a nine stranded β-barrel with mostly anti-parallel β-strands in the orientation of 
β1↓β2↑β3↓β4↓ß5↑β6↓β7↑β8↓β9↑. In addition, a two strand β-sheet (β1↓β9↑) protrudes 
out of the β-barrel parallel to the barrel axis. Besides, there is a two turn α-helix hanging 
outside of the β-barrel structure. In the protruding β-sheet, one strand is the N-terminal 
part of the molecule, whereas the second strand is the C-terminal strand of VP26. The N- 
and C-terminal of the molecule comes together to form this β-sheet. The N-terminal β-
strand is the longest in the molecule, having around 50Å in length; this β-strand is the 
part of the β-barrel as well as the protruding β-sheet. The pore of the β-barrel is highly 
hydrophobic in nature with side chains from three Phe, seven Ile, two Leu, five Met and 
four Val, a total of 21 hydrophobic side chains lining the inner pore surface. The 
approximate dimensions of the β-barrel are 38.5 Å (height) and 15.5 Å (diameter). We 
suggest that this pore, similar to the β-barrel pore of rVP28, may allow the binding of 













Figure 4.7 Ribbon Diagram of rVP26 monomer 
The β strand is colored green, while α helix and loop are colored as red and blue 
respectively. The N and C termini are labled. Figure was prepared using the programs 






4.2.4 Oligomerization of rVP26 
 
The oligomerization of rVP26 was investigated by gel filtration chromatography, 
SDS-PAGE and native gel. All the experiments showed an apparent molecular mass of 
20 KDa that corresponded to a monomer in solution. Only one molecule of rVP26 is 
observed in an asymmetric unit. Interestingly, rVP26 crystallized in R32 space group 
which has a three fold axis. The crystal packing showed a trimeric arrangement within 
the crystal lattices from the symmetry related molecules (Figure 4.8).  
 
Non-reduced SDS-PAGE and western blot analysis on the purified WSSV in 
Figure 4.9 showed the presence of trimer (~66KD), dimer (~44 KD) and monomer 
(~22KD, the most abundant species) of VP26. The arrow indicates the result 
corresponding to MALDI TOF TOF MS. Similar to the rVP28 trimer, we speculate that 
formation of the trimer may be the desirable aggregated form of this protein in the viral 
envelope. The monomers of the trimer may be held together by very weak interactions 
that are but not sufficiently strong to retain its oligomerization state in solution. The 
immuno-electron images of VP26 that are shown in Chapter three indicate that the 
observed spike-like structure should be a trimer.  
 
Similar to the rVP28 trimer, a channel is formed by the protruding N terminal 
region and the wall of the β-barrel from each monomer of the rVP26 trimer. There are 
several water molecules present in the channel. The height and diameter are 
approximately 58 × 12 Å. The channel may allow the passage of ions or small molecules, 








Figure 4.8 Ribbon Diagram of rVP26 trimer  
A) The rVP26 trimer (Crystallographic symmetry related molecules). Each monomer is 
shown in different color.  B) Top view of the VP26 trimer. Figures were prepared using 
the programs MOLSCRIPT (Kraulis 1991) and Raster3D (Merrit 1997). The N and C 












Figure 4.9 Western blot analysis of WSSV by anti-VP26 
 
The bands were detected by anti-VP26 IgGs and the corresponding gel was excised for 




4.3 Comparison of VP26 and VP28 
 
4.3.1 Structure Homolog of VP28 and VP26 
 
A search of structural similarities for both full length rVP26 and rVP28 using the 
DALI (Holm and Sander 1995) database failed to recognize significant matches to any 
known structure. Interestingly, rVP26 and rVP28 display strong structural as well as 
sequence homology among themselves. The structural superposition of rVP26 on rVP28 
gave an rmsd of 2.6Å for 144 Cα atoms, as shown in Figure 4.10, with a sequence 
similarity of ~36%. The structure based sequence alignment revealed that most of the 
structurally invariant residues are located at β1, β3, α1 (equivalent of α2 in rVP28), β4 
and β5. The rVP26 and rVP28 monomers possess a pore of similar size that is very 
hydrophobic in nature. The hydrophobic side chain residues lining inside the pore are 
quite conserved in these two proteins (Figure 4.11, Figure 4.12 and Figure 4.13). The 
most significant difference between them is an extended β-strand in rVP26 and an α-
helix in rVP28 as their protruding parts. In the case of rVP26, the N-terminal part and the 
C-termial strand come together to form a two stranded ß-sheet (β1↓β9↑) protruding out 
of the β-barrel and parallel to the barrel axis. Whereas in rVP28, a long α-helix is 






Figure 4.10 Stereo Cα superposition of rVP28 and rVP26  
 
Cα of rVP28 in blue and rVP26 in green is shown. The superposition was generated 
using the program O (Jones et al. 1991), using the consered residues as the starting point. 











Figure 4.11 Structure-based sequence alignment of rVP28 and rVP26 
 
 
The alignment was performed using the program O (Jones et al. 1991). The secondary 
structural elements and the sequence numbering for VP26 and VP28 were shown at the 
top and the bottom respectively. The conserved residues are highlighted in red as well as 









Figure 4.12 Simulated annealing Fo-Fc omit map showing the conserved 
region of rVP28 
 
All the residues shown in the figure as well as all the atoms within 3Å of these residues 
were omitted prior to refinement and map calculation. The map was contoured at a level 










Figure 4.13 Simulated annealing Fo-Fc omit map showing the conserved 
region of rVP26 
 
All the residues shown in the figure as well as all the atoms within 3Å of these residues 
were omitted prior to refinement and map calculation. The map was contoured at a level 






Furthermore, an interesting feature of these two proteins is their extreme opposite 
charges on the surface, although the inner pore region of the β-barrel maintains a strong 
hydrophobic environment with highly conserved residues lining the pore. The rVP26 
trimer (crystallographic symmetry related molecules) depicts patches of positively 
charged residues on the surfaces, whereas the rVP28 trimer depicts patches of negative 
charged regions (Figure 4.14). It has been reported that VP28 will interact with VP26 by 
far western blot analysis and pulldown assay (Xie et al. 2006; Xie and Yang 2006). 
However, it is unclear that what these kinds of charge distribution contribute to the 
function of the proteins such as the interaction between these envelope proteins or with 
receptors on host cells.  
 
Here we propose the trimeric VP26 and VP28 models along with the viral 
envelope. The trimer arrangement of VP26 and VP28 matches well with the shape of the 
spike-like structure in EM images after the treatment of Tween 20 (sees Figure 3.6 A-D, 
as well as inserts Figure 3.6 D). It has been proven that viral structural proteins can exert 
multiple functions by adopting different conformations (Hartlieb & Weissenhorn, 2006) 
such as the Ebola virus matix protein VP40 was monomers when targeted to cellular 
membranes but change its conformation to form hexamer via specific interactions of the 
N-terminus (Nguyen et al., 2005). We propose that VP28/VP26 of WSSV could also 
adopt a different conformation for different function, in which the trimer of VP28/VP26 
may play an important role in membrane fusion during viral infection. However, the 
questions that what is the factor to trigger the trimerization of these two proteins and 











Figure 4.14   The molecular surface representation for VP26 and VP28 that anchor the 
proposed viral envelope by the transmembrane (TM) domain. 
 
VP26 trimer (crystallographic symmetry related molecules) depicting patches of 
positively charge surfaces. Whereas, VP28 trimer, part of one asymmetric unit depicting 
the negatively charged regions. These figures were prepared using the program GRASP 
(Nicholls et al. 1991). The immuno-electron microscopic image of WSSV stained against 
VP26 and VP28 shows the spike-like structure appearance for VP26 and VP28 after 
Tween20 treatment. Shape of the spike-like structure matches well with trimer 







4.3.2 Comparison with Other Viral Proteins 
  
The β structure is one of the most common structures for viral structural protein 
and has been found in various viral proteins in RNA viruses from plant, insect and animal 
origins ((Rossmann and Johnson 1989), in double-stranded DNA viruses such as 
adenovirus (Roberts et al. 1986), PRD1 (Benson et al. 1999) and SV40 (Stehle et al. 
1996), and in dsRNA viruses such as blue tongue virus (Grimes et al. 1998) and 
orthoreovirus (Reinisch et al. 2000). The β structures of VP26 and VP28 reveal 
interesting structural similarities between these two proteins as well as with several 
apparently unrelated virus types, although neither VP28 nor VP26 shares significant 
sequence homology with known structural proteins from any other viruses.  
 
However, a search of structural similarities for both full length rVP26 and rVP28 
using the DALI (Holm and Sander 1995) database failed to recognize any significant 
matches to any known protein structure. The DALI search shows that the highest 
structural homology is with the gamma COP appendage domain of an intracellular 
trafficking pathway protein (pdb code 1 pzd; rmsd is 3.3 Å for 87 Cα atoms of rVP28 and 
89 Cα atoms of rVP26). The only viral protein structures that show partial structural 
similarity were VP7 protein of Bluetongue virus (pdb code 1bvp; rmsd is 3.6 Å for 82 Cα 
atoms of rVP26), A21 fragment of human coxsackievirus (pdb code 1z7z; rmsd is 3.6 Å 
only for 72 Cα atoms of rVP28) and the capsid protein of carnation mottle virus (pdb 
code 1opo; rmsd is 3.6 Å for only 64 Cα atoms of rVP28 and 3.7 Å for only 63 Cα atoms 
of rVP26). Structurally the most common feature among these proteins is the presence of 
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a β-barrel structure, which is exposed on the outer surface. The topologies of these 
proteins are, however, differenced from each other.  
 
Unlike the predominant eight-stranded jelly roll topology, VP26 and VP28 has a 
nine stranded ß-barrel that is folded into a novel topology and has not been seen in any 
other virus up to date. The novelty of the structure of the major envelope proteins of 
WSSV from any other virus to date therefore places WSSV outside of any of the 
structurally linked groupings that have been identified so far. This unique feature of 
WSSV is consistent with the phylogenetic tree of the WSSV DNA polymerase genes, 
showing that WSSV is not related to any of the larger dsDNA virus family (Chen et al. 
2002b). This further supports the proposition that WSSV should be a representative of a 












4.3.3 Implications on Gene Duplication 
 
VP24 is another important envelope protein of WSSV and interestingly it is also 
highly homologous to VP26 and VP28 with 41% and 46% sequence similarity 
respectively (Figure 4.15). Similar to VP26 and VP28, a highly hydrophobic region in the 
N-terminus of VP24 might represent a transmembrane region. From the homolog of 
VP26 and VP28 and the conservation of the sequence, we can hypothesize that VP24 
adopts a nine-stranded β-barrel fold with a hydrophobic pore similar to that observed for 
VP26 and VP28. However, the expression and purification trials on full-length VP24 or 
the truncated form invariably resulted in the production of an insoluble protein.  
 
Sequence comparison of VP24, VP26 and VP28 revealed that these three proteins 
are highly related and most likely arise from by gene duplication. The structure similarity 
of VP26 and VP28 further confirms this view. As the β sheet angle reflects packing of 
the hydrophobic pore, it should also be conserved upon gene duplication. Conversely, 
horizontal gene transfer would be less likely to yield a virus in which all three proteins 
would possess the same β sheet angle. Thus we believe that the structures of VP26 and 
VP28 bear evidence that support their evolution by gene duplication within the viral 
genome. A similar example can be seen in the outer coat proteins P3-V1, P3-V2 and P5 
of Bacteriophage PRD1. All these proteins have similar β barrel structure of same β 









Figure 4.15 Sequence Alignment for VP24, VP26 and VP28 
 
The sequence alignment of VP24, VP26 and VP28 were analyzed by DNAman. The 
identity residues are highlighted in black. The residues with similar properties are 
highlighted in blue.  
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It is surprised that WSSV encodes three most abundant envelope proteins of 
similar structure. One possible explanation is that these membrane anchor proteins can 
aggregate on the surface of membrane with β-barrels in which there are no "edge" with 
unfulfilled hydrogen bonding. The presence of similar hydrophobic barrel indicated that 
these three proteins most probably are capable of forming homo- and heteromultimers. It 
is recently reported that VP28 interacts with VP26 and VP24 to form a complex (Xie et al. 
2006; Xie and Yang 2006). Intermolecular interactions between thee similar structures 
may play a very important role in virus morphogenesis.  
 
Another way to explain the highly similar structure to assume that these proteins 
have been evolved with different functions in the WSSV virion such as VP26 was 
previously reported to be capable of binding to actin or actin-associated proteins (Xie and 
Yang 2005). Or they maybe related with infection to different host cell as the virus has a 
broad range of hosts including salt and brackish water penaeid, crab, spiny lobster, 
freshwater shrimps and crayfishes. However, whether these three proteins are just a 
redundant copy of each other for backup or tave been evolved with functional divergence 








4.3.4 Implications on membrane fusion 
 
Viral structural proteins can exert multiple functions by adopting different 
conformations (Hartlieb & Weissenhorn, 2006). For example, the Ebola virus matix 
protein VP40 was shown to form monomers when targeted to cellular membranes but 
change its conformation to form hexamer via specific interactions of the N-terminal 
domain (Nguyen et al., 2005). We propose that VP28/VP26 of WSSV could also adopt a 
different conformation for different function, in which the trimer of VP28/VP26 may 
play an important role in membrane fusion during viral infection. 
 
Enveloped viruses gain entry into the cytoplasm by the fusion of their lipid 
envelope with the host cell membrane and the virus–induced membrane fusion is 
triggered by conformational changes of viral envelope proteins (Da Poian et al. 2005). To 
date, two classes of virus membrane-fusion proteins have been defined based on their key 
structural features (Kielian 2006; Kielian and Rey 2006). Viruses that are currently 
assigned to Class I or Class II are listed in Figure 4.16A. The Class I  membrane-fusion 
protein is mediated by the refolding of the fusion protein to a highly stable rod-like 
structure with a central trimeric α-helical coiled coil. The Class II membrane-fusion 
protein undergoes an oligomeric rearrangement during fusion, converting from the 
metastable prefusion dimer to a considerably more stable homotrimer conformation. β 
structure is the predominant secondary structure of Class II fusion protein. The details of 
the structure features of the proteins in these two classes are list in Figure 4.16B. The 















Figure 4.16 Fusion Proteins of Class I and Class II  
 
A) Class I or Class II virus fusion proteins B) Comparison of Class I & Class II virus 






Though, VP26 and VP28 are not highly homologous to any of the viral envelope 
fusion proteins, it retains the ß-barrel as well as trimer architecture similar to other viral 
envelope fusion proteins such as E1 structural protein of Semliki Forest Virus (SFV) 
(Gibbons et al. 2004). Previous study has shown that VP28 plays an important role in the 
systemic WSSV infection in shrimp (Li et al. 2005a) and VP28 can bind to shrimp cells 
as an attachment protein only in a low pH condition and can help the virus enter to the 
cytoplasm (Yi et al. 2004).   It has been well established that some of the enveloped 
viruses enter the cells by endocytic pathway and this fusion depends on the acidification 
of the endosomal compartment. More recently it has been shown that the interaction 
between the host and WSSV is mediated through the host protein PmRab7 and VP28 
(Sritunyalucksana et al. 2006). Rab proteins act as molecular switches to control 
trafficking of endocytic vesicles within cells, as well as their subsequent fusion to 
endosomes. Considering this we suggest that the fusion of WSSV viral envelope and the 
host membrane through VP26 and VP28 is triggered by the exposure to low pH in the 
endocytic pathway or the combination of receptor binding and low pH. 
 
This completely different fusion mechanism also indicates that WSSV is a very 
unique virus that is not closely related to any other virus, underscoring the distinct 
taxonomic position of WSSV among invertebrate viruses. The many questions on the 




















5 General Conclusion and Future Studies 
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The characterization of viral structural proteins especially the envelope proteins is 
of significant importance to study the taxonomy of the virus, its mechanism of infection 
and also the assembly process of the mature virus. Due to the lack of a suitable shrimp 
cell line and a low homology with other proteins of known function, we took the 
structural approach to study WSSV envelope proteins.  
 
A novel envelope protein, VP300, was identified by mass spectrometry. A 
localization study using Western blotting and immuno-gold-labeling electron microscopy 
are performed to confirm that VP300 localizes in WSSV envelope, not in the 
nucleocapsids. The neutralization assay showed that anti-VP300 IgGs functions to delay 
or neutralize the infection of WSSV to shrimp. Perhaps the antibody of VP300 could bind 
to envelope spikes on the virion and prevent virus uncoating or the attachment of the 
virus to the cell surface or virus uncoating. Further study on VP300 would be helpful to 
realize the mechanism of the viral infection. Up to now, no efficient method has been 
found to prevent the infection of shrimp by WSSV. Antibodies against VP300 could be 
used directly as a passive immune strategy to control the WSSV infection and also might 
be a choice for the virus control in the shrimp industry.  
 
In this study, localization of VP26 with immuno-electron microscopy has also 
been investigated. Compared with the highly confirmed envelope protein of VP28, the 
location of VP26 in the virion is still unclear. VP26 was first reported as a nucleocapsid 
protein (van Hulten et al. 2000), and later reported as an envelope protein (Zhang et al. 
2002b). However, most recent publications claimed that VP26 is a linker (Xie and Yang 
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2005), or a tegument protein (Tsai et al. 2006). Clarification of the location of VP26 
should improve our understanding on function of the protein. In this study we have first 
used Tween 20 treatment to separate viral envelope from the nucleocapsid and then 
localized VP26 by immunogold labeling. Both the VP26 and VP28 were clearly observed 
on the outer surface of the virus envelope by electron microscopy and that is the very first 
time we observed the spike-like structure in WSSV envelope. 
 
As the continuation of our effort to understand the structure and function of 
WSSV proteins, we determinate the crystal structure of two major envelop proteins VP26 
and VP28 from WSSV, the first two structural envelop proteins to be reported from 
WSSV for the first time. We have analyzed the three dimensional structures of VP26 and 
VP28 and postulated that VP26 and VP28 might fuse with the envelop membrane by 
their N-terminal transmembrane domains. A search for full length VP26 and VP28 
structural similarities using the DALI (Holm and Sander 1995) database failed to 
recognize any significant matches. Interestingly, VP26 and VP28 display strong 
structural as well as significant sequence homology. Both proteins adopt the β-barrel 
architecture with a protruding N-terminal region. The mushroom-like shape of the 
trimeric VP26 and VP28 matches well with the spike structure we have observed in the 
localization study. They are highly likely function to interact with host receptor proteins 
or fuse with host cell membrane, representing a different model from the fusion proteins 
of class I and class II. 
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This is the first report that structures of WSSV major envelope proteins. It greatly 
inspires us to further determine the structure of other envelope proteins or nucleocapsid 
proteins as they have important role in mechanism of viral morphogenesis and the 
infection mechanism.  
 
There are four major envelope proteins (VP19, VP24, VP26 and VP28) proteins 
that consist almost 80-90% of the entire envelope. We have speculated that VP24 may 
adopt a β-barrel structure with a hydrophobic pore similar to that of VP26 and VP28 
because of their very high sequence homology. However, VP19, which almost constitutes 
30% of the envelope, has no sequence similarities to proteins from WSSV or other 
known viruses. Structural elucidation of VP19 will be extremely important for studying 
the evolution of WSSV and also for the infection mechanism of this unique virus. A brief 
attempt at the expression and purification trials of full length VP19 resulted in an 
insoluble protein. Considering a predicted transmembrane region at the middle of 
sequence, we will try to express the two sides of the fragment that may represent two 
domains that are located outside and inside of the membrane respectively.   
 
VP281, with a cell attachment RGD motif, is supposed to play an important role 
in mediating WSSV infectivity (Huang et al. 2002a; Liang et al. 2005). As another 
candidate for a structural genomics study, this protein has been successfully expressed 
and purified as a soluble protein in the bacterial system as we mentioned in Chapter three. 
However, we are still unable to grow any crystal of this protein from the crystallization 
trials. We suspect that the failure of crystal growth is because of a probable floppy 
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domain in the protein that might cause aggregation. So in the future work, the following 
approachs can be used to remove this floppy region. The first one is to construct different 
truncated forms of VP281, such as to remove the N-terminus or C-terminus. The second 
approach is to remove the flexible region by performing limited proteolysis. An 
experiment using intact proteins and small amounts of exogenously added proteases can 
be performed to isolate a fragment that will be more amenable to crystallization. The 
ratio of protein to protease and the reaction time can be varied for limited proteolysis. 
Once identified, the protease resistant fragment can be purified for crystallization.  
 
More recently it has been shown that the interaction between the host and WSSV 
is mediated through the host protein PmRab7 and VP28. Rab proteins are known to act as 
molecular switches to control trafficking of endocytic vesicles within cells, as well as 
their subsequent fusion to endosomes. It has been reported that once the interaction of 
these two proteins was blocked by their specific antibodies the efficiency of the WSSV 
infection were greatly reduced. Thus we can try to solve the complex structure of VP28 
and PmRab7 to figure out the key residues which are involved in their interaction. Based 
on these residues, peptides or small molecules can be designed to inhibit their interaction.  
 
Besides the structure determination, an infection assay can be done to figure out 
the key factors affecting the viral infection. Such as this assay can be done at various 
different pH to prove the proposal that acidic pH is essential for viral infection of WSSV. 
These experiments can also lead to the question of why pH will affect viral infection and 
whether this is somehow related to the charge distribution on VP26 and VP28. Similar to 
  117
the neutralization study by antibodies, an experiment can be set up to use mutant VP26 or 
VP28 to map out the host receptor binding region of these proteins. Purified wild type 
protein should be able to neutralize WSSV infection as it should compete with the virus 
to the host cell receptor. By mutating residues on the surface of the protein, the mutant 
may lose the ability to inhibit WSSV infection. Those mutated residues can be identified 
to be essential for interaction with the host receptor. However, the neutralization assay is 
not that easy to be carried out because that it is very hard for us to select out the WSSV-
free shrimps or crayfishes for the assay. Majority of the shrimps or crayfishes we brought 
for experiments are tested to be the carrier of the WSSV and unable to be used in the 
neutralization assay. Therefore, we will continue to screen out the shrimp (crayfish/crab) 
cell lines for in vitro reproduction of WSSV what is suitable for the infection assay. 
 
 In a conclusion, after the 3D structures of these envelope and nucleocapsid 
proteins are solved, we can obtain more comprehensive information for further research 
on host-virus interaction, the maturation and assembly of the virus particles and answer 
many other important questions. Besides that, infection assays can be done to figure out 
the key factors that affect viral infectivity of WSSV and select the inhibitors to block the 
interaction to the host cell receptor that can greatly reduce the infection. Finally, our 
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A. Media and solutions 
 
 
LB broth (per liter) 
 
To 950 mL of MQ H2O, add: 
Bacto-tryptone 10 g 
Bacto-yeast extract 5 g 
NaCl   10 g 
 
Dissolve solutes. Adjust pH to 7.0 with 1 M NaOH. Adjust volume to 1L with 
MQ H2O. Sterilize by autoclaving. 
 
 
2 × YT medium (per liter) 
 
To 950 mL of MQ H2O, add: 
Bacto-tryptone 16 g 
Bacto-yeast extract 10 g 
NaCl   5 g 
 
Dissolve solutes. Adjust pH to 7.0 with 1 M NaOH. Adjust volume to 1L with 
MQ H2O. Sterilize by autoclaving. 
 
 
SOC medium (per liter) 
 
To 950 mL of MQ H2O, add: 
Bacto-tryptone 20 g 
Bacto-yeast extract 5 g 
NaCl   0.58 g 
 
Dissolve solutes. Add 10 mL of 250 mM KCl. Adjust pH to 7.0 with 1 M NaOH. 
Adjust volume to 980 mL with MQ water. Sterilize by autoclaving. Allow to cool to 60°C 
or less, and then add 20 mL of sterile 1M glucose. Add 10 mL of sterile 1 M MgCl2 just 
prior to use. 
 
 
Tfb I (per liter) 
 
To 950 mL of MQ H2O, add: 
CH3COOK  2.94 g 
RbCl   12.1 g 
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CaCl2·2H2O  14.7 g 
MnCl2·4H2O  9.9 g 
Glycerol  150 mL 
 
Adjust pH to 5.8 with dilute acetic acid, add MQ H2O to 1 L and autoclave. 
 
 
Tfb II (per liter) 
 
To 950 mL of MQ H2O, add: 
MOPS   2.1 g 
CaCl2   11.1 g 
RbCl   1.21 g 
Glycerol  150 mL 
 
Adjust pH to 6.5 with 1 M NaOH, add MQ H2O to 1 L and autoclave. 
 
 
10 × TNE buffer (per liter) 
 
To 950 mL of MQ H2O, add: 
Tris   6.05 g 
NaCl   5.85 g 
EDTA   0.292 g 
 
Adjust pH to 7.4 with 1 M HCl and add MQ H2O to 1 L. 
 
 
10 × TE buffer (per liter) 
 
To 950 mL of MQ H2O, add: 
Tris   6.05 g 
EDTA   0.292 g 
 
Adjust pH to 7.4 with 1 M HCl and add MQ H2O to 1 L. 
 
 
10 × TN buffer (per liter) 
To 950 mL of MQ H2O, add: 
Tris   6.05 g 
NaCl   9 g 
 





B. Restriction enzymes 
 
All restriction enzymes were bought from New England Biolabs (NEB). 
 
BamH I NEB, #R0136L 
EcoR I  NEB, #R0101L 
Hind III NEB, #R0104L 
Xho I  NEB, #R0146L 
 
 
C. Other enzymes 
 
Protease K     Sigma, #P2308 
T4 DNA polymerase    NEB, #M0203S 
T4 DNA ligase    NEB, #M0202L 
T4 polynucleotide kinase   Promega, #M4103 
DNA Taq polymerase    Promega, #M1665 
RNase-free DNase I    QIAGEN, #79254 
Sequencing grade modified trypsin  Promega, #V511A 










High pure PCR product purification kit  Roche, #11732668001 
Rapid DNA ligation kit    Roche, #11635379001 
QIAprep spin miniprep kit    QIAGEN, #27106 
QIAquick gel extraction kit    QIAGEN, #28706 
RNeasy mini kit     QIAGEN, #74106 
OneStep RT-PCR kit     QIAGEN, #210212 
BigDye® terminator v3.1 cycle sequencing kit Applied Biosystems, #4337455 
Hi-Di formamide     Applied Biosystems, #4311320 
RC DC protein assay kit    Bio-Rad, #500-0119 
 
 
F. Crystallization screen kits 
 
Index      Hampton Research, HR2-144 
PEG/Ion Screen    Hampton Research, HR2-126 
Crystal Screen Kit    Hampton Research, HR2-110 
Crystal Screen 2    Hampton Research, HR2-112 
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Natrix      Hampton Research, HR2-116 
MembFac kit     Hampton Research, HR2-114 





High Speed Centrifuge     Beckman, J2-21 
Ultracentrifuge      Beckman, XL-90 
MicroPulser® Electroporator      Bio-Rad 
Thermal Cycler      Bio-Rad 
ABI PRISM™ 3100 Genetic Analyzer  Applied Biosystems 
Voyager-DE™ STR BioSpectrometry Workstation  Applied Biosystems 
4700 Proteomics Analyzer with TOF/TOF™ optics  Applied Biosystems 
Ultimate™ LC system     Dionex LC Packings 
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